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INTRODUCTION 
Obesity remains a medical enigma (1). Defying clear defin¬ 
ition as a clinical entity, a myriad of therapeutic approaches 
to obesity have been attempted over the years with a remarkably 
consistent low degree of success (2, 3)» The approaches have 
been diverse - medical, surgical, psychiatric, social - and 
reflect the complexity of the problem of the obese state. Re¬ 
cently an apparent increase in interest has arisen in the treat¬ 
ment of obesity, as reflected in the medical literature. This 
has likely been catalyzed by the relatively recent growing en¬ 
thusiasm and concomitant growing fear and skepticism over newer 
methods of treatment: intestinal bypass surgery and behavior 
modification. A careful re-evaluation of the treatments of 
choice for the obese patient is needed at this time. In addi¬ 
tion to an examination and comparison of results of various 
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treatment methods, it is important to reconsider the basic under¬ 
standing of obesity in order to rationally approach the prob¬ 
lem therapeutically. Epidemiologic and etiologic considera¬ 
tions should not be forgotten, lest our means may obscure our 
goals. 
The potpourri of treatment approaches may be indicative of 
the confusion and misunderstanding rampant among physicians 
concerning obesity. However, an eclectic approach could be 
the result of good clinical judgement in individualizing treat¬ 
ment for a very complex problem. More disturbing than the 
variety of therapeutic approaches is the relative lack of any 
approach. Obesity is often not defined as a clinical problem 
and, for a variety of reasons is too often ignored by the 
physician in the clinical setting. Perhaps the greatest de¬ 
terrent is the fact that obesity is so difficult to treat suc¬ 
cessfully. This is undoubtedly discouraging, but clearly not 
the only factor, as physicians treat many disorders despite 
very limited success. Underlying the problem of the treat¬ 
ment of obesity is the realization that obesity, unlike most 
other clinical disorders, is to a great extent a moral issue 
(4). Obesity is often simplified into issues of will power 
and gluttony - morally-charged items - and the burden and 
responsibility of care is frequently thrust back upon the 
shoulders of the obese patient. Although some advantage may 
be achieved through bolstering the patient's motivation and 
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also limit-setting his dependency needs, the moralistic ap¬ 
proach has serious drawbacks. It often reflects a physician's 
ignorance about the obese state, and in its insensitivity to 
the patient may be a disservice. Again, a more rational ap¬ 
proach to the obese patient can be found after understanding 
the basics of the clinical disorder and reviewing the results 
of different therapeutic approaches. 
One difficulty in the study of obesity results from the 
incremental nature of this disorder rather than it being an ail- 
or-none pathologic entity. Clinically, however, obese patients 
may present with seemingly different medical problems. Commonly 
seen is the mild or moderately obese patient whose obesity is 
incidental or at most questionably associated with other health 
problems for which he seeks relief. Here, obesity is usually 
looked upon as a symptom (5) and may or may not be viewed as an 
important problem requiring treatment. The massively obese pa¬ 
tient, on the other hand, perhaps presenting with a Pickwickian 
syndrome, severe hypertension or other serious problems felt to 
be directly related to a more obvious life threatening obesity, 
is usually approached more aggressively for the treatment of his 
major disorder of obesity. The medical literature rarely makes 
a distinction between these two groups of obese patients. Such 
a distinction is increasingly needed in obesity research now 
that the more risky surgical approach is gaining acceptance. 
This study will review literature about obesity in general. 
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realizing that dividing obesity into quantified categories is of¬ 
ten unnecessary and impractical. However, some attention will 
be focussed upon the problem of massive obesity and its 
treatment. 

-5- 
THE OBESE PATIENT 
Definition 
A dictionary defines obesity as "excessive fatness, 
corpulence, or overweight." (6).Jean Mayer stresses that 
obesity is a pathologic condition, characterized by an accu¬ 
mulation of fat much in excess of that necessary for optimal 
body function. (8).Salans similarly defines obesity as "a 
disorder in which there is an abnormal enlargement of the adipose 
tissue mass." (9).Mayer makes a distinction between obesity 
and overweight, the former meaning too much fat, the latter 
less specifically meaning too much weight. The heavily muscled 
and boned individual is likely to be found overweight, but may 
not be obese. Swings in water balance may also affect weight 
by up to several pounds. A theoretical distinction between 
obesity and overweight exists. Accepting the concept of 
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Mtoo much fat," one must consider the limitations of normal 
body fat content. In men, normal body fat content increases 
with age from about 18-20% at age 20 to about 35% at age 60. 
For v/omen the respective numbers are 20-25% and 25-30%. 
(10).Equating obesity with adiposity is limited by the va¬ 
lidity of these ranges of normal values. Is an elderly thin 
man too fat because 30% of his weight is adipose tissue? It 
must also be kept in mind that normal ranges are usually de¬ 
fined by assuming a normal distribution and then choosing a 
somewhat arbitrary boundary such as that defined by the stan¬ 
dard deviation from the mean, establishing the upper 16% of 
the sample as above normal. (8).The concept of normalcy is 
further obscured when considering obesity in terms of hypo¬ 
thalamic regulation. If an individual's hypothalamic regu¬ 
latory system is set to maintain fat stores at a high level (11), 
then that person's obesity is a normal or ideal set point for 
his body composition (12). 
Although George Bray defines obesity as an enlargement 
and/or hyperplasia of adipose cells, he stresses his conviction 
that obesity is a symptom rather than a disease. (21)"It rep¬ 
resents one visible consequence of ingesting more calories than 
are being utilized" (5). He derives this notion from the appar¬ 
ent heterogeneity of the obese state. Hilda Bruch states thats 
"Obesity...must be looked upon as the outward manifestation of 
a variety of underlying disturbances in weight and appetite 
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regulation" (14). Even Mayer, who is convinced that a somatic 
regulator underlies the process, sees obesity as multicausal, 
a common symptom of numerous conditions, and therefore offering 
multiple cures.(4) 
Measurement 
Accepting that obesity is a symptom of diverse causes 
characterized by an overaccumulation of body fat, its clinical 
measurement and assessment is a problem. Indirect rigorous 
laboratory measurements offer the most scientifically sound 
method of estimating degree of adiposity. Densimetric, hydro¬ 
metric (dilution), and body potassium determination methods have 
been developed (4), but are not practical for clinical use. Of 
anthropometric measures, that of skinfold thickness remains the 
best accepted. The validity of this measure is based upon the 
belief that subcutaneous fat, evenly distributed, is directly 
proportional to total body fat in an individual for a given age 
and sex. It requires the use of a special caliper and some min¬ 
imal skill at least in measuring the thickness of a pinched skin¬ 
fold, usually over the triceps. This measurement is compared 
with standardized tables. Although Mayer sees this method as 
simple, practical, and precise (15)# its use in clinical settings 
has not been popular and it remains a diagnostic tool of the 
researcher and specialist. 
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Measurement of height and weight remains the most used 
method for determining obesity. Standard tables take into 
account height, body build, sex and age in setting limits for 
normal weight. The inadequacy of using weight to measure obes¬ 
ity has been mentioned, and can be both falsely high or low, as 
Keys found twenty per cent of underweight men in the upper one 
third of fatness distribution (16). The tables are derived from 
insurance company data (17) which has been criticized as of 
limited usefulness because of population skewing (18), To re¬ 
duce inaccuracy introduced into normal range values by variations 
in non-adipose tissue contributing to weight, the height-weight 
tables show different normal weight ranges for small, medium and 
large frame. This variable relates to Sheldon's earlier work on 
somatotypes (19). Sheldon defined three basic genetic body types: 
endomorphic, mesomorphic, and ectomorphic, based upon seventeen 
anthropometric measurements. Not only do these variations in 
body build or type make obesity interpretation difficult, but 
the somatotype itself may be closely associated with a predis¬ 
position to obesity. Seltzer and Mayer found obesity to corre¬ 
late with endomorphy in adolescent girls (20). In spite of the 
limitations of the standardized height-weight tables, Bray found 
a good correlation (r=+0.9) between table assessment of obesity 
and adiposity measured densimetrically (21). To reduce the over- 
influence of height in the use of the tables and increase accu¬ 
racy, the ratio of weight/height squared, called body mass 
index, was found to best correlate with adiposity (16). 
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Subjective assessment of fatness can in most instances be 
crudely accurate and may be helpful in detecting obese patients 
who are not overweight. The mirror test is practical, although 
often unreliable: if you look fat, you are. 
TABLE 1 
STATISTICAL BULLETIN METROPOLITAN LIFE INSURANCE COMPANY NO. 40 
NOVEMBER-DECEMBER, 1959 DESIRABLE WEIGHTS IN INDOOR CLOTHING 
Height 
Weight (lb.) 
Small frame Medium frame Large frame 
5'2" 112-120 118-129 126-141 
3" 115-123 121-133 129-144 
4" 118-126 124-136 132-148 
MEN 5" 121-129 127-139 135-152 
6" 124-133 130-143 138-156 
Aged 7" 128-137 134-147 142-161 
25 8” 132-141 138-152 147-166 
and 9” 136-145 142-156 151-169 
over 10" 140-150 146-160 155-174 
11" 144-154 150-165 159-179 
6'0" 148-158 154-170 164-184 
1" 152-162 156-175 168-189 
2" 156-167 162-180 173-194 
3" 160-171 167-185 178-199 
4" 164-175 173-190 182-204 
Height 
Weight 
Small frame Medium frame Large frame 
4'10" 92-98 96-107 104-119 
11" 94-101 98-110 106-122 
5' 0" 96-104 103-113 109-125 
WOMEN 1" 99-107 104-116 112-128 
2" 102-110 107-119 115-131 
Aged 3" 105-113 110-122 118-134 
25 4" 108-116 113-126 121-138 
and 5” 111-119 116-130 125-142 
over 6" 114-123 120-135 129-146 
7" 118-127 124-139 133-150 
8" 122-131 128-143 137-154 
9" 126-135 132-147 141-158 
10" 130-140 136-151 145-163 
11" 134-144 140-155 149-168 
6" 0" 139-1^-8 144-159 153-173 
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Prevalence 
Not altogether independent from the determination of 
normal values for weight, skinfold, or indirectly measured 
adiposity, is the prevalence of obesity. On the height-weight 
tables (17) the upper limit of desirable weight is about five 
per cent above the mean of a given range for a height and frame. 
Desirability, in this case, has been based upon mortality data. 
The U.S. Society of Actuaries in i960 found the following per 
cent deviation from desirable weight (17,22) 
% Of Population Weighing X% From Ideal Weight 
Age (Years), Sex -10% + 10% 10-19% +20% 
20-29 a 13 31 19 12 
50-59 a 4 63 29 34 
50-59 9 4 67 21 46 
Although this very large study was limited to insured indivi 
duals, smaller studies in the U.S. and Great Britain have 
found between 18-34% of the adult population to be at least 
10% overweight (23- ■25). In the New York City public school 
stem, 10% of the children are overweight (26). 75% of obese 
children are believed to go on to become obese adults, while 
25%> of obese adults were obese children (27). A more recent 
Public Health Service report estimates that 25-45% of Ameri¬ 
can adults are greater than 20% overweight (28). Generally, 
clinical obesity is considered significant when excess weight 
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is at 10-15%, and 20-30% overweight is excessive obesity (29). 
Risks and Consequences 
Although the prevalence of obesity is impressively large, 
the clinical significance of obesity lies in the associated 
risks, hazards, and liabilities that are caused by or related 
to the obese state. Two basic schools exist on the hazards 
of obesity. Mann has called obesity the "nutritional spook," 
(30) emphasizing that the evidence is weak correlating obe¬ 
sity with the disease states it is usually said to be associated 
with. Furthermore, Mann is impressed that "obesity is a re¬ 
latively incurable disorder," (27) which would imply that 
the treatment may often be more drastic than the disease. 
The more traditional point of view stresses that obesity is a 
menace (31,4). 
The hazards of obesity could be categorized as follows: 
1- increased disease risk; 2- effect on established disease 
or normal function; 3- social and psychological effects; 4- 
costs and hazards of treatment. Mortality statistics for 
life insurance holders in the 1930's document, if only crude¬ 
ly, the considerably increased mortality risk for overweight 
persons (see table 2) (4). Overall, the mortality for the 
overweight population is 150% that of the normal. Furthermore, 
the mortality increases as the percentage of overweight in¬ 
creases. 
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TABLE 2 
PRINCIPAL CAUSES OF DEATH AMONG MEN AND WOMEN RATED FOR OVERWEIGHT 
ATTAINED AGES 25-74 YEARS 
Ratio of Actual to Expected Deaths According to Estimates 
of Contemporaneous Mortality Experience on Standard Risks 
Metropolitan Life Insurance Company, Ordinary Department 
Issues of 1925 to 1934, Traced to Policy Anniversary,1950 
MEN WOMEN 
Cause of Death Deaths 
% Actual 
of expected 
Deaths Deaths 
% Actual 
of expected 
Deaths 
Principal cardiovasc.- 
renal diseases 1867 149 1103 177 
Organic heart dis., 
coronary artery dis 1377 142 697 175 
Cerebral hemorrhage 247 159 226 162 
Chronic nephritis 243 191 180 212 
Cancer, all forms 385 T7 4 76 Too 
Stomach 62 85 34 86 
Liver and gall bladder 33 168 46 211 
Pancreas 19 93 21 149 
Breast — -- 81 69 
Uterus — -- 103 121 
Diabetes 205 383 235 372 
Tuberculosis (all) 24 21 20 35 
Pneumonia 98 102 78 129 
Cirrhosis 96 249 32 147 
Appendicitis 76 223 41 195 
Hernia and intestinal 39 15ft* 31 ra> 
obstruction 
Gall bladder dis. (all) 32 152* 30 188* 
Biliary calculi 19 206 50 2B4 
Stomach and duoden. ulcer 30 67 --- -- 
Pueroeral conditions — — 43 162 
Suicide 63 78 23 73 
Accidents, total 177 111 74 135 
Auto 76 131 27 120 
Falls 32 131 ** *** 
*Based on mortality rates on Standard risks for 1935-1939 
NOTE: Percentages which have been underlined indicate statisti¬ 
cally significant deviations from experience on Standard 
risks. 
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Serious lifeshortening diseases said to be associated 
with obesity include hypertension, diabetes mellitus, sudden 
death, hyperlipidemia, respiratory insufficiency, toxemia 
of pregnancy, thromboembolic disease, and congestive heart 
failure (31-33). Diseases of moderate to severe morbidity 
said to afflict the obese include gallstones, osteoarthritis, 
varices, hernias, menstrual disturbances, depression, anxiety 
and anesthetic risk (31f 34, 28). Minor disorders such as 
dermatitis, flat feet, impaired agility, and heat intolerance 
can impair life style and, as has been reported in obese chil¬ 
dren, can lead to serious accidents such as burns (35). Num¬ 
erous other problems less often associated with obesity have 
been reported. 
The Framingham Study found hypertension ten times as pre¬ 
valent in those 20% or more overweight as compared to normal 
weight (36). Although other studies also show a significant 
association between overweight and high blood pressure (37» 38), 
the degree of obesity has not been well correlated with hyper¬ 
tension (39). In fact, the correlation between blood pressure 
and adiposity has been found to be of low order in several 
studies, between .05 and 0.3 (40,36). McDonough et. al. found 
a positive correlation in black women, but not black men in 
their study in Georgia (41). Body weight has been found to 
better correlate with hypertension than has body fat (36,42). 
The use of weight as a measure for obesity rather than indirect 
measures of adiposity allows for the influence of body build 
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per se to remain uncontrolled for in most studies. Mayer and 
Seltzer have found a positive correlation between mortality 
and body build (20, 4). Obese individuals are most often 
endomorphic in somatotype, and least often ectomorphic (4). 
The contribution of bone and muscle mass as compared to adipose 
tissue mass to increased mortality and morbidity in overweight 
individuals is not yet clear. 
The increased mortality for overweight people from heart 
disease and especially coronary artery disease (see table 2) 
implies a strong association. The Framingham Study found a 
correlation for angina and for sudden death for those 20?S 
or greater overweight (43). Keys also found a correlation, 
but this disappeared when he considered only normotensive 
overweight individuals (44). To add to the uncertainty, 
other studies have failed to show a significant correlation 
between overweight and coronary artery disease (45,46). As 
obesity appears to be associated with hypertension and hyper¬ 
lipidemia (47, 48), and these conditions predipose to coronary 
artery disease (49), it is reasonable to infer that obesity 
is a potential culprit at least by association and possibly 
by cause in a subpopulation of obese patients that have ab- 
normalties in their blood pressure and serum lipids. Fur¬ 
thermore, it appears that obese individuals who suffer myo¬ 
cardial infraction with or without their obesity playing an 
etiologic role are compromised in their ability to recover (43). 
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Whether this increased rate of sudden death in the obese is 
due to an increased hydraulic load upon the heart (39) or 
poor collateral circulation due to the relative inactivity 
associated with obesity (50), or a combination of these 
factors is not known. 
The distinction between cause and association must be 
kept in mind in these considerations of the hazards of obesity. 
Associations between obesity and disease are often found, 
particularly with the use of retrospective studies. Disease 
caused by obesity is better assessed through prospective studies 
and requires difficult and sometimes unfeasible control of 
multiple variables. For example, if a prospective study 
shows a significant association between obesity and the on¬ 
set of coronary artery disease, we do not know whether a cause 
and effect relationship exists or that some other factor such 
as decreased exercise (50-52) is primary to both conditions in 
these individuals. 
The relationship between obesity and abnormal glucose 
tolerance and diabetes mellitus is less controversial. (See 
table 2). Here, the disease state is more clearly related to 
the physiological alterations which obesity causes in car¬ 
bohydrate metabolism. The obese have been found to have in¬ 
creased fasting insulin levels, theorized as an adaptation 
from active obesity (state of accumulation of fat) for in¬ 
creased efficiency and rapidity in the removal of glucose 
from the blood (53). It appears that the obese often have a 
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decreased carbohydrate handling capacity, that they require 
more insulin to act upon adipose and muscle cells (exacer¬ 
bated by an increased cortisol secretion), and that this is 
clinically reflected in an abnormal glucose tolerance test and 
sometimes leading to overt diabetes mellitus (5^#17). In Sims' 
study on human hyperphagia, normal male volunteers were overfed 
to study the changes caused by exogenous obesity. In the 
group which successfully reached 20% overweight, a diminished 
glucose tolerance, increased insulin levels, and increased 
peripheral insulin resistance were found (55t57). 
A major mechanism of disadvantage in obesity is that of 
mechanical burden; obese people overwork their systems. Al¬ 
though this is still somewhat controversial in the cardio¬ 
vascular system, it is more obvious in the muscular-skeletal 
system. Arthritis, fractures, and other muscular-skeletal 
problems are often troubled by excess weight. Respiratory 
difficulty, manifested in extreme in the Pickwickian syn¬ 
drome, is believed to be another mechanical consequence of 
obesity (49). When obesity is a mechanical burden to health, 
the degree of obesity would seem to correlate with the degree 
of disability. 
Other mechanisms of disadvantage have been suggested. 
Hypothetically, the increased food intake of the obese intro¬ 
duces the increase of ingestion of noxious substances (27). 
Indeed, laboratory animals have been found to live longer 
on a diet restricted to three-quarters of their usual intake 
\ 
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as compared to a group on an ad libitum diet (58). Decreased 
physical activity might also play a role in disease predisposi¬ 
tion in the obese. While a number of studies have shown an 
association between inactivity and obesity (50-51* 59-61), and 
some have implicated inactivity in an etiologic role (52), Sims' 
work on experimental human obesity suggests that inactivity can 
be secondary to the gain of excess weight (56). 
The potential social and psychological consequences of 
obesity are mostly obvious and can be devastating. A long 
social history of prejudice against fat people exists. The 
obese are somehow viewed as physically and morally absurd. 
Anthropological precedents of obesity as an indicator of 
success still have some meaning in our culture, but the pre¬ 
stige accrued upon the "fat cat" or the "buddha" in certain 
settings is more than offset by the negative aspects of being 
considered physically and often morally grotesque. Mayer is 
struck by the social attitudinal aspect of obesity (4), and it 
may indeed be this quality of obesity, rather than a more 
"medical" one, that makes it such a difficult disorder to 
deal with successfully in a medical model. 
Social ostracism and prejudice naturally relate to the 
psychological trauma of obesity. Although it is difficult 
to separate psychological problems that are causal from those 
consequential to obesity, disturbances in self-esteem, sexu¬ 
ality, and body image, as well as neurotic depression may be 
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manifested. Hilda Bruch emphasizes that obesity is associated 
with many psychological disorders, rather than just one. In 
obese children, their development centers around their fat¬ 
ness. While eating freely, they tend to avoid activities and 
contacts, not unlike the situation described for the symbiotic 
preschizophrenic family (14). A number of investigators have 
found evidence of greater psychopathology in obese versus 
nonobese patients on the basis of psychological testing or 
clinical evaluation (62, 63). These studies, however, do not 
determine whether the psychological disturbance is primary or 
secondary to the obesity. The psychological aspects etiological- 
ly related to obesity will be discussed in another section. 
Not to be forgotten amongst the hazards of obesity are 
those resulting from weight reduction therapy. In addition to 
the side effects of drugs, fasting, intestinal bypass surgery 
(to be discussed when considering these treatments), abused 
methods, and folk remedies, even moderate dieting can produce 
untoward reactions. Stunkard has reviewed the literature link¬ 
ing diet with depression and concludes that untoward emotional 
reactions to diet are a real phenomenon especially in patients 
with juvenile onset obesity undergoing severe caloric restric¬ 
tion as outpatients (64). Bruch warns that: 
...for many people overeating and being fat 
is a balancing factor in their adjustment 
to life. Ineffective as it is, it represents 
the best form of adaptation that such people 
have been able to make. (65) 
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Thus is the concept viewing obesity as a depressive equiva¬ 
lent for some individuals (66). 
Other hazards have been reported. Mortality data indicate 
significantly raised death rates in overweight people for a 
number of surgical disorders such as appendicitis, hernia, 
gall bladder disease, and intestinal obstruction (17). Other 
relatively obvious risks exist, although seldom documented. 
For example, physical examination of the abdomen is often 
difficult in the obese patient and important physical findings 
are frequently not detected. Less obvious risks have also 
been reported, such as the association between nephrotic 
syndrome and massive obesity (67). 
The purported benefits of obesity should be mentioned. 
Mortality data imply a significant decreased risk for breast 
cancer, tuberculosis, peptic ulcer, and suicide. It is un¬ 
known whether these benefits are truly obtained through adi¬ 
posity or by some other variables common to the group of 
overweight patients. The theorized anti-depressant effect of 
obesity has been mentioned, and Simon found overweight Air 
Force men less depressed than their normal peers (66). 
In sum, the hazards of obesity are numerous and diverse, 
including physical and psychological problems, from trivial 
to life threatening, and through a variety of pathogenetic 
mechanisms. Controversy arises concerning the degree that 
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obesity predisposes to hypertension and its related serious 
diseases of the cardiovascular-renal systems. Diseases more 
clearly related to physiological disturbances brought on by 
the obese state, such as diabetes mellitus, are more closely 
associated with obesity. 
The benefit of weight reduction in terms of relieving the 
hazards of obesity is a major consideration for initiation of 
therapy. Marks found a return to normal mortality rates for a 
group that had successfully lost weight (37). This data, 
however, is crude and imperfect and a good study testing whether 
weight loss in obese subjects lowers their risk for certain dis¬ 
eases is relatively unfeasible. Mann asserts that weight reduc¬ 
tion for hypertension is not reasonably worthwhile considering 
the infrequency of successful treatment (27). 
An individualized risk-benefit analysis seems prudent in 
the decision to treat patients for obesity. The following salient 
points should be kept in minds 
1) Obesity carries with it numerous and various potential 
consequences to an individual’s physical and emotional health. 
2) Weight reduction will relieve or prevent these conse¬ 
quences to a varying and uncertain degree, depending largely 
upon the physiological relationship of adiposity or over¬ 
weight to the consequence, and the reversibility of the con¬ 
sequence. 
3) Weight reduction therapy is generally lengthy and costly, 
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accompanied by a variety of potential side effects, depending 
on the method, and, for the most part, is unsuccessful in the 
long run. 
Therefore, no hard and fast rule can be applied to the ques¬ 
tion to treat or not to treat. Patient mctivation is, of 
course, another important variable, and will be discussed when 
considering treatment efficacy. 
Classification 
The classification of obesity has undergone several revi¬ 
sions in its basic scheme this century. Van Noorden intro¬ 
duced the endogenous-exogenous classification at the turn of 
the century (5)» and it is still often used today. Exo¬ 
genous implies that the obesity is caused by overeating, 
while endogenous obesity implies some explainable physiologic 
or genetic mechanism. While of some practical use, such as 
differentiating between endocrine causes and so-called dietary 
causes, this classification falls short in its theoretical 
accuracy. There is formidable evidence, to be discussed 
shortly, that would lead us to believe that so-called exogenous 
obesity is no more exogenous or unphysiologic than the endo¬ 
genous obesity seen in Cushing's syndrome. Clinical use of 
this categorization is further hampered by connotations that 
these labels have taken on over the years: exogenous obesity 
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as the result of an incorrigible and immoral gluttony versus 
the respectable and treatable disease-caused endogenous obesity. 
A more recent development has been the so-called anatomic 
classification: hypertrophic versus hyperplastic obesity. A 
potentially important categorization arose on finding hyper¬ 
plasia of adipocytes in juvenile onset obesity, and only 
hypertrophy without increased cellularity in the adipocytes 
of patients who first became obese in adulthood (72-75). The 
potential therapeutic relevance of these findings are felt in 
light of the understanding that weight reduction will decrease 
adipocyte size but not cell number (74, 76). Interest has been 
sparked in early life and the factors that increase cellu¬ 
larity. Knittle and Hirsch found they could modify cell number 
in young rats nutritionally, implicating the importance of 
ovemutrition in early life in juvenile onset obesity (77). 
A number of classification schemes based upon etiology or 
clinical types have been devised (4,5)(78,79). (See table 3). 
While Mayer limits his classification to genetic, hypothalamic, 
and endocrine categories (4), Bray adds to this group the cate¬ 
gories of inactivity, drugs, and essential obesity (5). 
Within this classification, simple obesity, considered as a 
genetic obesity, is by far the most common, and the type that 
interests us the most. 
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table 3 
CLASSIFICATION OF OBESITY IN MAN: ETIOLOGIC 
Modified from Bray (5) 
Hypothalamic 
Tumors 
Solid (Frohlich syndrome) 
Leukemia 
Inflammatory 
Traumatic 
Increased intracranial pressure 
Empty sella 
Pseudotumor cerebri 
Endocrine 
Cushing's syndrome 
Insulinoma 
Castration 
Stein-Levinthal syndrome 
Pregnancy 
Hypothyroidism 
?Inactivity 
Genetic 
Simple; Juvenile onset 
Laurence-Moon-Biedl syndrome 
Hyperostosis frontalis interna 
Alstom's syndrome 
Prader-Willi syndrome 
Drugs 
Phenothiazines 
Estrogens 
Cyproheptadine 
Etiology 
The understanding of the etiology of a disease is often 
the key to the development of an effective treatment. Obesity 
hardly well conceptualized as a disease state, suffers the 
dilemma of etiological uncertainty, which has likely contri¬ 
buted to its relative refractoriness to a variety of imperfect 
t 
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therapies. However, obesity is the result of any of a multi¬ 
plicity of causes, and likely can be approached, theoretically 
at least, through a number of potential cures (4). 
Mayer has stressed the importance of animal studies in 
understanding human obesity: "Is man indeed unique as far as 
normal - and pathological - fat accumulation is concerned?"(4) 
Animal husbandry is an example of genetics operating in obesity 
outside of the laboratory setting. A number of rodent models 
exist of genetically determined obesity (4,68). The yellow 
mouse transmits obesity by autosomal dominance, while several 
other mice strains show autosomal recessive transmission. 
Obesity is also observed in a number of inbred strains such 
as the New Zealand obese mouse and the Japanese K K mouse. 
Although these genetically determined obese animals have a 
number of characteristics in common, such as hyperphagia, 
inactivity, hyperglycemia, and hyperinsulinemia, no clear 
biochemical basis for explaining the obesity has been deter¬ 
mined (5). 
Human studies indicate that genetics plays a role in obesity. 
Newman found identical twins separated at birth to be signifi¬ 
cantly closer in weight than a group of fraternal twin controls 
(69). More recently Shields found separated monozygotic twins 
closer in weight than dizygotic twins reared together, impli¬ 
cating genetics as more influential than environment in body 
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weight (70). Work earlier this century showed stoutness to be 
transmitted as a Mendelian inherited dominant trait (71). 
Gurney found the following in the population he studied (39). 
Parents Stout Offspring 
stout ; x stout 73% 
stout X nonstout 40% 
nonstout x nonstout 9% 
Worth mention are a number of reported hereditary syndromes 
that include obesity in their constellation: Laurenee-Moon- 
Biedl, hyperostosis frontalis interna, Alstrom's, and the 
Prader-Willi syndrome (5). 
Although the evidence is strong that hereditary factors 
contribute to the emergence of the formerly labelled exo¬ 
genous obesity (less controversially called simple obesity by 
Mayer (4) ), it is less clear to what extent this is true. A 
multiplicity of genes is likely involved (4). Evidence suggest 
that hyperplastic obesity, the juvenile onset type, may be 
genetic. 
Endocrine obesities, it should be stressed, are relatively 
rare as compared to simple obesity. Cushing's syndrome is 
perhaps best known, the hyperadrenocorticism producing a 
characteristic clinical and laboratory picture, including a trun¬ 
cal, posterior cervical, and superclavicular fat distribution. 
Hyperinsulinism is another endocrine abnormality that can 

produce obesity (81). The pathophysiology of insulinomas is 
relatively clear, but the hyperinsulinism and associated 
weight gain frequently known to precede diabetes is less well 
understood in its relationship to obesity. Sims showed that 
hyperinsulinism and abnormal glucose tolerance could occur 
after a significant weight gain in overfed subjects (55)» 
although evidence of these insulin changes preceding obesity 
in the prediabetic has not been established. 
Of some appeal is the concept that obesity is the result 
of a hypometabolic state. The endocrinological prototype of this 
phenomenon is best seen in hypothyroidism. These patients have 
a decreased metabolic rate and tend to gain weight, although 
it is unclear how much of this weight gain is due to fat and 
how much is fluid. Hypothyroidism, however, needs be verified 
by thyroid function tests and not diagnosed solely on the 
basis of a basal metabolic rate (BMR) measurement, as has 
been done so often in the past. Although it is quite possible 
that the obese bum up less energy in their daily activities (82), 
BMR studies have mostly shown no difference from normals (29). 
Passmore found that obese patients gained more than thin pa¬ 
tients when overfed for fourteen days (83,84). Such evidence 
that the obese are not as capable of burning up extra fuel 
may relate to Roily's observation in 1921 that the thermal 
response to food is decreased in obesity (29). It is theorized 
by some that the thermal effect of eating - the specific dynamic 
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action of food - allows normal individuals to maintain weight 
with varying intakes. In Miller's thermogenesis theory the 
specific dynamic action decreases in obesity (85). Galton 
has postulated a possible enzyme deficiency based on his evi¬ 
dence that the obese have reduced ability to oxidize glyceral 
phosphate, leaving more glycerol available for fat syntheses(86). 
These metabolic findings and theories are of yet unclear 
importance in the etiology of obesity. More likely may be 
their importance in the maintenance of the obese state. 
Craddock summarizes that the metabolic differences between 
the obese and normal are "...of degree only and are due to 
adaptation to an abnormal intake of food at some time." (29) 
Other endocrinological diseases associated with obesity 
are a number of varying gonadal disorders. Male hypogonadism 
is often associated with a truncal obesity. Stein-Leventhal 
syndrome, or polycystic ovary disease, consists of hypo- or 
amenorrhea, often infertility, hirsutism, and sometimes 
obesity in young women. These women show increase adrenal and 
ovarian function, and a hyperphagia and weight gain that 
has suggested hypothalamic involvement in the process, al¬ 
though there is little data to support this (87). Hypothala¬ 
mic lesions have also been suggested in Frohlich's syndrome, 
inwhich truncal obesity is associated with sexual infantilism, 
and often other abnormalities. This syndrome may be associated 
with tumors and other disorders of the hypothalamic pituitary 
area and, like the rare hereditary Laurence-Moon-Biedl syndrome. 
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obesity and genital atrophy are assumed but as yet unproven 
to be the result of hypothalamic dysfunction. 
Although of great importance theoretically, hypothalamic 
obesities are rare. Three pathologic groups exist: traumatic, 
inflammatory, and neoplastic. The most common cause has been 
the craniopharyngioma (5). Animal experiments have uncovered 
the physiology of the hypothalamic regulation of satiety and 
hunger. Destruction of the ventromedial area of the hypothalamus 
caused a number of different animals to overeat until obese. 
Destruction of lateral hypothalamic areas produced animals that 
would not eat. On the basis of these and other findings the 
mechanism for the regulation of food intake has been postu¬ 
lated: a satiety center in the ventromedial nucleus and a 
feeding center in the lateral hypothalamus, with connnections 
between the two centers (4, 49). 
Subsequent theories have integrated the appetite centers 
into a scheme of abnormal regulation. "Glucostatic," "lipo- 
static" and "aminostatic" theories of food intake have emerged 
with the basic idea that some blood factor, falling below a 
critical level, stimulates hypothalamic centers through speci¬ 
fic receptors, producing the drive to eat. Mayer's glucostatic 
theory has received widest interest (4, 29), postulating that 
hypothalamic glucoreceptors register low levels of effective 
blood glucose in some individuals causing them to eat more. 
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V/hat has emerged has been the concept of obesity, in many 
if not most cases, as a disorder of hunger and satiety regu¬ 
lation. It seems likely that an individual, based upon his 
genetic predisposition and early nutritional experience, has 
his regulatory mechanism for food intake set at a certain 
level. For the obese, this level is set high. Indeed, there 
are many physiological and behavioral similarities between the 
obese man and the normal hungry person (12). Both obese and 
hungry subjects have been found to eat faster (88), to more 
readily eat in a new environment (1$, and to prefer good over 
bad tasting food (33» 89) more so than normal controls. Schacter 
has conducted a number of studies of eating behavior that impli¬ 
cate poor regulation of intake or an insensitivity to physio¬ 
logical cues in the obese (88, 90). These behavioral eating 
patterns of obese and hungry subjects are similar to those found 
in animals with experimental ventromedial hypothalamic lesions. 
A physiological index of hungry, free fatty acid in blood, is 
found to be inflexibly elevated in obese subjects (91). 
The clinical implications of this view of obesity are pro¬ 
found. If the obese patient "overeats" to meet the needs of a 
true physiologic hunger, how successful can he be in first losing 
weight and then maintaining his weight against a chronic hunger? 
Such a situation could help explain both the high failure rate 
for long term weight reduction and the phenomenon of dieting 
depression. 
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Another seemingly important factor in the unsimple etio¬ 
logy of simple obesity is that of inactivity. Basically, 
obesity is the result of a positive caloric balance: the energy 
absorbed is greater than the energy expended. This balance is 
exquisitely regulated in normal individuals who can generally 
eat as they please and maintain their weight, even though an 
imbalance of only one hundred calories per day could lead to 
an accumulation of ten pounds of fat over a year. Rats were 
found to maintain a stable weight on an ad libitum diet when 
they were exercised between one and five hours per day. Below 
one hour, however, the regulatory mechanism seemed to fail, 
and the rats gained weight (92). Mayer*s study of Indian indus¬ 
trial workers showed a similar phenomenon. (See figure 1). 
Over a range of light work jobs through very heavy work jobs, 
workers maintained normal weights by natural variations in 
their caloric intake. However, workers in sedentary jobs 
weighed more than their active fellow workers and showed a cal¬ 
oric intake greater than others expending more energy (52). 
Other studies have linked obesity with inactivity, if not as a 
cause, then at least as a factor contributing to its mainte¬ 
nance. Chirico used pedometers (50) and Bullen used time 
lapse motion pictures (51) to show that obese subjects were 
less active than controls. Sims, who overfed normal volunteers, 
found his subjects more inactive when they became obese (55)* 
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FIGURE 1 
BODY WEIGHT AMD CALORIC INTAKE AS 
A FUNCTION OF PHYSICAL ACTIVITY IN MAN 
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A behavior as complex as eating must include consideration 
of psychological factors in its etiology. In the 19^0's 
many considered obesity as the expression of a neurosis (29). 
This simplistic view has fallen out of vogue in light of a 
more sophisticated neuro-humoral understanding of obesity. 
However, evidence still implicates the importance of psycho¬ 
logical factors. A number of studies have found obese sub¬ 
jects to score more abnormally than controls on a variety of 
psychological tests (62,63,93)* Bruch and Yudkin have articu¬ 
lated the concept of compensatory eating (65*9*0: a basic need 
to have a large body to compensate for inferiority feelings. 
Stressful or anxiety-provoking situations cause some obese 
individuals to eat more (95)• Stunkard postulates that some 
obese have serious disturbances of body image (96). In this 
maze of theory we must respect Bruch's reminder that obesity is 
probably associated with a number of psychological disorders, 
not one, and her caveat that identifying psychological problems 
as a cause of obesity versus an effect of weight reduction is 
very difficult (14). Craddock's statement seems functional 
even if of unproven accuracy: "The majority of obese people 
probably have no obvious psychologic factors affecting their 
tendency to obesity" (29). Nevertheless, Bloom and Clarke's 
invention of the descriptive term "Obese Carboholic" (97) 
reflects the view that many clinicians take towards their 
obese patients: victims of a psychological addiction and 
physiologic craving for food. 
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Interacting with the psychological factors relevant to 
becoming obese are a number of social factors. The Mid-Man- 
hattan Study found only 5% of upper class women overweight 
contrasted to 30% for the lower class (98). Social eating 
and exercise habits, education, ethnic and societal differ¬ 
ences, and cultural sexual role differences can all affect 
one's tendency to become obese. 
The inadequacy of classifying simple obesity as a genetic 
obesity is obvious after considering the complex metabolic, 
psychological, and social factors relevant. However, such a 
classification can be helpful in defining other obesities in 
which the etiology is better understood. Craddock's concept 
of the etiology of simple obesity well depicts the interplay of 
a variety of factors that may lead to obesity (29)• 
(See Figure 2).___ 
° ~ Figure 2 
THE ETIOLOGY OF SIMPLE OBESITY 
( Modified from Craddock (29) ) 
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Summary and Conclusions 
The definition, measurement, prevalence, hazards, classifi¬ 
cation, and etiology of obesity have been reviewed and con¬ 
sidered. Accepting the definition of excess adiposity, clini¬ 
cal measurement is practically limited to indirect measurement, 
height and weight tables being accurate for most cases, and 
skinfold thickness measured by caliper offering greater accuracy. 
Prevalence data indicate that obesity is very common, although 
reports vary. The hazards of obesity are numerous and varied, 
some obvious and others controversial, some trivial and others 
life-threatening. V/eight reduction will clearly alleviate and 
prevent certain problems of the obese, but it is of uncertain 
benefit for other problems. Obesity has been classified and 
reclassified, based upon newer etiological understandings. 
Numerous disorders of both man and animal are associated with 
obesity, but these are relatively rare as compared to simple 
obesity. Recently divided into juvenile and adult onset types 
based upon anatomic differences of the adipose tissue, simple 
obesity appears to be influenced by genetic, metabolic and be¬ 
havioral factors in its genesis and maintenance. Although 
several appealing theories exist, a clear etiologic understanding 
of obesity awaits further progress, and weight reduction therapy 
through establishing a negative caloric balance can be approached 
via a number of routes by which obesity is influenced. 

-35- 
treatment 
Introduction 
The decision as to whether or not to treat an obese pa¬ 
tient is a problem that has been discussed in the section 
considering the hazards of obesity and benefits of weight re¬ 
duction. Worth reitering is the point that this is a dynamic 
decision for the physician and the patient in which many var¬ 
iables need be considered in a risk-benefit model. Mayer's 
contention that weight reduction is desirable for all obese 
patients (8) lacks realism, while Mann’s view dubbing obesity 
as the "nutritional spook" (30) seems unduly conservative in 
its approach. More appropriately, no hard and fast rules 
need be made concerning indication and contraindiction as long 
as the patient's total well-being is of utmost priority. 
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A distinction ought to be made between patient education 
and actual patient treatment for obesity. The former includes 
disclosure to the patient that he is clinically overweight, 
that this condition is hazardous to his health, and that it is 
advisable for him to reduce his weight towards normal. This 
is clearly a service to most patients and will undoubtedly 
often result in some small degree of success, especially when 
the physician-patient relationship is particularly strong. 
However, a clear and well-thought out treatment plan is more 
appropriate if the physician seriously seeks a successful out¬ 
come for the patient. It has been shown that some fifty per 
cent of obese patients seen are not treated, even when greatly 
overweight (100). 
The wide variety of treatments for obesity reflect both 
the multiplicity of etiologic avenues that have been theorized 
and the failure of any single method to be satisfactorily effec 
tive for most patients. However, a common denominator exists 
in all reasonable methods: a negative caloric balance must 
be achieved to lose weight, and over the long run, caloric 
balance must be equilibrated to avoid regaining the weight. 
Feinstein has pointed out that although a plethora of 
methods exist, there is little scientific data to help the phy¬ 
sician decide which is best. In evaluating methods, he offers 
several caveats: success should be based upon relative achieve 
ment of target weights; dropout need be considered; follow-up 
need be considered; guard against bias (101). 
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Several criteria have been devised to measure the success 
of weight reduction methods, such as rate of weight loss, 
amount of weight lost, or per cent of excess weight lost. These 
criteria, Feinstein has noted, are not valid in that they are 
too greatly affected by initial weight or early program dropouts. 
His reduction index relates loss to both initial weight and 
surplus weight, but without being influenced by duration (102). 
Reduction Index= % of weight loss x relative initial 
obesity = weight loss/weight surplus x initial weight/ 
target weight x 100 
Feinstein considered an index of sixty as successful. Target 
weights can be determined from height/weight tables or based 
upon clinical judgment. Since its introduction some fifteen 
years ago the reduction index has seldom appeared in the litera¬ 
ture and the degree of its use is unknown. 
Diet 
The diet has long been the mainstay of obesity therapy. 
Its appeal lies in that it is "natural”, introduces a minimum 
of iatrogenic manipulation, is inexpensive, and is syntonic 
with the concept that obesity is an eating disorder. And, 
indeed, calories do count - a concept that appeals to the lay 
scientific mind of contemporary man. The basal metabolic rate 
for man calculates to about 1000 calories/square meter/day; 
the 5'10" 150 pound man having a surface of about 1.7 m^. 
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Daily activity burns calories in excess to the BMR an average 
of sixty per cent for adolescents and some forty per cent for 
those over the age of sixty (103). However, energy expendi¬ 
ture can vary markedly, ranging between 2400 and 6000 calories/ 
day for a male (4). A pound of fatty tissue contains about 
3500 calories (104). 
Despite these metabolic realities, dieting has been largely 
unsuccessful in the long term treatment of obesity. Stunkard 
reviewed literature reported over a ten year period, finding 
under twenty-five per cent of all patients undergoing treat¬ 
ment having lost up to twenty pounds, and about five per cent 
having lost as much as forty pounds (2). Finding only eight 
follow-up reports, he located only two out of one hundred 
patients who lost tv/enty or more pounds and who maintained 
their loss after two years. A number of other reports and esti¬ 
mates give these success rates for dieting regimens; ten-forty 
per cent of patients lose weight after one year; one to thirteen 
per cent maintain some loss after five years (23f29»101,105-109). 
A wide variety of diets have been used to achieve an overall 
decrease in caloric intake. Simplest of these is the prescribed 
low caloric diet that is well-balanced - what might be called 
a "common sense" diet. Obviously, this common sense approach 
usually fails, or otherwise it would preclude the numerous 
other diets that have appeared. Significantly decreasing food 
intake is clearly difficult for most obese persons, explainable 
by some of the psychological and physiological factors mentioned. 
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Defaulting is a major impediment to success. Bulk agents, 
most notably methylcellulose, have been tried in the hope 
that satiety could be achieved through both psychologic and 
physiologic mechanisms of eating and filling the stomach with 
moderately large amounts of food. A large study found no 
benefit of use of bulk agents (110) and it is suggested that 
naturally bulky foods - fruits and vegetables - can serve as 
well (4). The use of artificial low carbohydrate foods and 
sweeteners is another attempt to lessen the burden of a de¬ 
creased caloric intake. Used widely in a program in which 
calories are truly saved, these "diet foods" can be helpful, 
but their impact has been minimized because of unpalatability, 
expense, the low appeal of synthetic chemicals in food, and 
their use without a well-planned reduction program. 
Because of the difficulty of compliance with the low 
caloric diet and its high failure rate, special diets have 
been devised that are less harsh in terms of decreased food 
but will purportedly reduce weight if adhered to because of 
manipulation of foodstuffs in the diet. The recommended 
balanced diet ought to contain a minimum of lk% protein, a 
maximum of 30% fat, and the remainder of calories as carbohy¬ 
drate (4). Kekwick and Pawan postulated that a fat mobilizing 
substance produced after fat ingestion led to an increased 
weight loss in subjects on diets high in fat over subjects on 
other isocaloric diets (111-115). Pennington began using the 
"high fat" diet on his obese patients with some success about 
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twenty-five years ago (116), and the diet was subsequently 
modified by Donaldson who added large water intakes to the 
regimen (29). Yudkin found that strict carbohydrate control 
was all that was necessary for a successful diet, allowing his 
patients a free fat and protein intake (117). Although others 
have demonstrated the effectiveness of low carbohydrate/free 
fat and protein regimens (118, 97)» Pilkington contends that 
the diet seems to work because of the high fluid retention of 
carbohydrates (119), while Young claims that evidence implies 
an increase in fat metabolism (120). Another metabolic mechan¬ 
ism that might favor a diet high in protein is the high specific 
dynamic action of this foodstuff which would theoretically dis¬ 
sipate some protein calories. 
The major advantage of the free diet is clear: make it easy 
enough for the dieter to allow success. Craddock, an advocate 
of the free diet, writes: 
That the free diet is satisfactory for use in 
general practice is shown by the fact that almost 
every patient who takes his dieting seriously can 
lose weight for a month or two even if he has not 
the motivation to maintain dietary control for a 
longer period (29). 
Such claims have been challenged, however, and a number of 
studies have found no benefit of special diets with a variety 
of foodstuff ratios over the balanced diet (121,122,129) Also, 
foods contain mixtures of fat, protein and carbohydrates and 
significantly altering the ratios of these foodstuffs from that 
of a normal diet is difficult to achieve. The benefit of the 
free diet is further obscured by the criticism that it is unsafe 
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nutritionally - particularly in promoting hyperlipidemia 
through a high fat intake - fails to guide the obese patient 
towards new healthier eating habits. 
Another special diet devised to make compliance easier 
has been the formula diet. Here, the patient is permitted one 
or several prepared nutriment fluid meals per day and no 
other caloric food. It claimed the advantage of being simple, 
safe, and by offering the patient a rigid but simple regimen 
to follow was conducive to high compliance and success. Although 
early trials were promising (102), the formula diet faded 
quickly as a popular method. 
Recently, Sohar carried out a follow-up study of 27 patients 
that had successfully dieted fourteen years previously. More 
than two-thirds of the group showed no substantial decrease from 
their pre-diet weight; only five had lost more than ten per cent 
of their weight, while three had gone on to gain more than ten 
per cent (123). Is dieting a worthwhile treatment? George Bray 
and George Mann, with long and scholarly interests in the field, 
think not (27,124). This view is derived with the following in 
mind: 1) dieting is often arduous and emotionally and physic¬ 
ally upsetting; 2) it is an expense (professional care) and 
inconvenience; 3) it often fails to reduce weight short term, 
and usually fails long term; 4) (Mann) - weight reduction is 
often unnecessary for the well-being of the patient. 
Why do diets usually fail? The concept that likens the 
obese person to a normal hungry person (12) (both neurohumorally 
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and behaviorally), discussed previously, allows us to under¬ 
stand how difficult it must be to voluntarily abstain from 
food in the face of a constant and powerful basic human drive: 
hunger. Psychological factors have also been mentioned, and the 
obese patients who use eating in response to or in relief of 
emotional stress (compensatory eating) (24) may find it ex¬ 
tremely difficult to diet. Weight loss in the dieter can be 
described in two phases: an initial fluid loss, often an 
encouragaing start, then followed by a slower and more gradual 
loss that represents the catabolism of fat (125). This second 
stage can be frustrating to both patient and physician. As 
discussed earlier, the obese are highly efficient in utiliz¬ 
ing calories, probably through metabolic adaptation (226, 83,84), 
and this is compounded by a tendency to adapt to caloric restric¬ 
tion by decreased energy expenditure (12?). The result is a 
disappointing degree of weight loss that is less than the 
predicted amount even though the patient has adhered to the diet. 
Another vital factor relevant to the success or failure of 
a diet is that of patient compliance. Feinstein found re¬ 
stricted environment programs - inpatient programs that assured 
the necessary discipline - superior to unrestricted environment 
programs, and found the degree of successful weight loss to be 
directly proportional to the amount of caloric restriction (102). 
Based upon his analysis of methods, Feinstein defined three inter- 
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I 
actional factors that influence diet adherence; 
1) Patient: variety of psychic factors; motivations 
2) Patient-physician relationship; role of the doctor; 
number of visits; clinic availablility; incentives by physician; 
physician attitude 
3) Diet program: factors which tend to keep patient 
on program - enthusiastic beginnings and novelties. 
He concludes that the particular diet is least important in 
success, that the physician - patient relationship is most 
important, and that "when a patient is ready to diet, he can 
lose weight with whatever method of caloric restriction is 
given him." 
The importance of motivation has also been noted by others. 
Craddock found that his obese patients v/ith medical reasons 
for losing weight did twice as well as his other obese pa¬ 
tients (29). Of note is that the best long term results of 
dieting for a large program were reported for the Anti-Coronary 
Club of New York - a group of highly motivated volunteers (109). 
The patient-physician relationship is of importance in any medi¬ 
cal regimen that calls for voluntary patient compliance. Crad¬ 
dock emphasizes the need to individualize therapy as best suited 
to each patient. Besides taking a history and doing a physi¬ 
cal examination, he administers a psychological test - the 
Shipman Anxiety/Depression Scale questionnaire(128) - to help 
determine neurotic tendencies that might alter treatment and 
prognosis. He stresses the importance of physician interest, 
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especially in terms of advising and educating the patient 
about a suitable program, and sees his patients every two 
weeks at first, and then monthly (29). As Hollenberg has stated 
Successful management (of obesity) when it dees 
occur, is the result of a knowledgeable and 
sympathetic physician having the time and the 
interest to meet repeatedly with a patient 
who has at least a modicum of insight into 
the condition and a considerable motivation 
to reverse it (29). 
Exercise 
The therapeutic partner to the diet is exercise. This is 
logical in light of our understanding that calories do count. 
The role of inactivity in the etiology of obesity has been 
discussed, as has been mentioned the wide range of caloric ex¬ 
penditure found in people with different activity levels. 
Exercise alone cannot be considered a reasonable weight reduc¬ 
tion program. As Mayer has shown, increased energy expenditure 
is naturally offset by increased caloric intake in the nondiet¬ 
ing individual (52). Increasing energy expenditure without a 
matching increase in intake can be an effective part of a 
weight reduction program. Energy expenditure is proportional 
to body weight for a given exercise, making this a self-cor¬ 
recting factor in the active person (4). A three mile walk in 
one hour burns only about three hundred calories, but Keys 
calculates that a 190 pound man v/alking an hour daily for three 
months will lose an additional ten pounds (129). (See Table 4) 
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TABLE 4 
ADDITIONAL WEIGHT LOSS FROM EXERCISE 
Modified from Keys and Craddock (29) 
One hour's walking daily (or 3/^ hour's bicycling 
or 1/4 hour's swimming or l/2 hour's tennis) 
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Two Months 
lb. 
Three months 
lb. 
130 2.2 4.4 6.5 
145 2.5 4.9 7.3 
l6o 2.8 5.5 8.1 
175 3.1 6. 0 8.9 
190 3.4 6.5 9.6 
225 3.9 7.7 11.3 
25b 4.3 8.6 12.7 
Craddock concludes: "an increase in the amount of regular 
exercise taken should be part of the weight reduction regime 
for every patient with no medical contraindications: (29). 
However, the benefit of exercise may not be so predictable. 
Buskirke has shown that when obese patients increase their 
energy expenditure and restrict their intake, they compensate 
by conserving energy for the remainder of their nonstrenuous 
activities (130). 
Little has been written about which individual factors are 
associated with a good or poor prognosis for successful treat¬ 
ment. Not surprising is the observation that obese adults who 
were obese as children are less likely to succeed in weight re¬ 
duction and maintenance (109). The recent anatomic distinction 
between juvenile and adult onset obesity may help explain this, 
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but psychosocial factors are also likely to be contributory. 
Also well known is that massive obesity is a more difficult 
problem than obesity of a more moderate degree. Again, several 
factors could easily explain this. Craddock, who admittedly 
sees little massive obesity in his practice, has identified a 
number of prognostic factors in his obese patient population (29). 
He reports that his patients with high incomes did better. This 
is probably a cultural phenomenon, and class values and educa¬ 
tion may play a role as well as enhance physician-patient rap¬ 
port. Craddock reports that patients with medical incentives 
to lose weight did twice as well as the other patients. The 
importance of motivation has been discussed earlier, and perhaps 
no motivation is as strong as a medical one. Of note is his 
observation that exercisers did better. Other favorable prog¬ 
nostic characteristics include male sex, married, and parents 
(29, 109, 242). Patients with a strong compulsion to eat do 
badly. Craddock concludes: 
The patient who has the best chance of dieting suc¬ 
cessfully. ..is a successful businessman or profes¬ 
sional man who has become moderately obese during 
his adult life, is married with children, emotionally 
mature, and with no marked tendency to depression. 
His success will be quicker if he can take extra 
exercise and if he has a medical reason for losing 
weight. Unfortunately, less than 10% of the patients 
with a weight problem who present themselves to a 
physician come into this category. 
Drugs 
While diet and exercise have the appeal of simplicity, their 
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relative lack of success has led to a search for a medical 
treatment for obesity. Bray predicts that ultimately a success¬ 
ful treatment for moderate or severe obesity will be pharma¬ 
cologic (131). 
However, no drug thus far has shown outstanding effectiveness 
and drug treatment is considered an adjunct to a dietary pro¬ 
gram and not a reasonable treatment without dieting. 
A great deal of experience exists with the use of appetite 
suppressing agents of the amphetamine type. These numerous 
agents, all bearing chemical resemblance to the parent compound 
D-amphetamine probably produce relative anorexia through stimu¬ 
lation of the ventromedial hypothalamic satiety center (4) or 
through another central nervous mechanism (132, 133)* although 
peripheral metabolic process have also been suggested as contri¬ 
buting to their effectiveness (134). The effectiveness of these 
agents on weight reduction over placebo has been documented in 
numerous studies (135-1^0)• Using well-controlled and double- 
1 
blind methods (138), the literature supports the effectiveness 
of these agents even in the face of the difficulty of isolating 
drug effect from variables related to the dieting regimen. Also 
well documented is the limited duration of these drugs' effects 
(141). Most of the above studies documented positive results 
for twelve weeks or less, and four to six weeks may be the 
optimal period for most patients (4). One small study found 
an anorexiant (diethylproprion) to be inferior to placebo after 

-48- 
one year of use (142). 
Another serious limitation to the usefulness of these agents 
is the associated side effects. Undesirable side effects re¬ 
semble those found with use of the prototype drug, amphetamine: 
central nervous stimulation effects - restlessness, anxiety, 
insomnia, and similar symptoms manifested in extreme by psychosis 
cardiovascular effects - including headache, palpitation and 
cardiac arrhythmias, angina, and other less common problems; 
excessive sweating; gastrointestinal effects-dry mouth, metallic 
taste, nausea, vomiting, abdominal cramps and alas, anorexia 
may be troublesome for those that are compensatory eaters (143). 
Psychic dependence and habituation are also associated with 
amphetamine abuse, and the antidepressant effects of these 
drugs add to their abuse potential. 
Although the amphetamine anorexiants generally have similar 
actions, differences in effectiveness and side effects have 
been claimed. Amphetamine-like drugs used in the United States 
for appetite suppression include: 
1) amphetamine 6) diethylproprion(Tenuate,Tepanil) 
2) methamphetamine 7) phenmetrazine (Preludin) 
3) benzphetamine (Didrex) 8) phendimetrazine(Dietrol,Plegine) 
4) phentermine (Ionamin, 
Welpo) 9) mazindol (Sanorex) 
5) chlorphentermine 
(Pre—Sate) 10) clortermine(Voranil) 
11)fenfluramine (Pondimin) 
Although comparative studies show some advantage of diethyl- 
proprion in terms of side effects (29)» the advantages of the 
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newer agents over amphetamine is not satisfactorily proven (143): 
Fenfluramine is a promising agent, causing drowsiness rather 
than restlessness and insomnia and is said to have a lower 
abuse potential (143, 144). 
Because of their short duration of effectiveness the anor- 
exiants can be used in several ways in a dietary program. Crad¬ 
dock lists the following indications: 1) to enable patient to 
maintain diet after initial motivation wanes; 2) to help certain 
depressed patients from the beginning; 3) short courses to 
help lose relapse weight; 4) diet failures (29). This reasonable 
and flexible approach emphasizes that these agents can be of 
use in a dietary program, but cannot be relied upon as the 
major contributor in weight reduction. Not only must the phy¬ 
sician be sensitive to the fact that these agents have unde¬ 
sirable side effects and abuse potential, but that this form of 
treatment by itself offers the patient little in terms of long 
term weight control. 
Other appetite suppressants have been used. The oral hypo¬ 
glycemic biguanide,, phenforrnin (DBI), has enjoyed some use 
for obese maturity-onset diabetics. Its purported success may 
result from its mechanism of action that lowers blood sugar 
without increasing endogenous or exogenous insulin, or may be 
a result of its side effects of ketosis, nausea, and metallic 
taste (143). In view of numerous contraindications and side 
effects, phenforrnin is a difficult drug to use and thus not 
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prescribed by many clinicians. Digitalis has been misused for 
weight reduction (147), anorexia being one toxic manifestation 
among other life-threatening ones. Its use for the treat¬ 
ment of obesity is irresponsible. 
The treatment of obesity by hormones has maintained theore¬ 
tical appeal based upon the suspicion or even conviction by 
many that obesity is fundamentally an abnormal metabolic and 
regulatory state. Thyroid hormone has received the most atten¬ 
tion, its use in obesity based upon the increased caloric 
utilization affected by the hormone. Contrary to the opinion 
of many obese persons, the thyroid status in obesity is not 
different from the normal (148-151) and the metabolic rate is 
within normal limits (152). Abnormal thyroid function has 
been reported, finding that some obese have altered binding 
of hormone (131), and have reduced clearance of T^ and T^ (145, 
146). Numerous studies over the last forty years have demon¬ 
strated that thyroid hormone can potentiate weight loss (153-159, 
124). However, follow-up studies indicate that the losses are 
not maintained after the drug is stopped (158-159)* This ten¬ 
dency to regain weight quickly is not well understood, but pos¬ 
tulated mechanisms include a continuance of increased appetite 
and bad eating habits which were developed during the hyperme- 
tabolic medicated state, or a decrease in physical activity 
secondary to fatigue and a temporary hypothyroidism after dis¬ 
continuance of the hormone (160). Another drawback of the 
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thyroid hormone induced weight loss is that much of the loss 
is from lean body mass. Bray found about one-fifth of thyroid 
induced weight loss to be from adipose tissue stores (151). 
The negative nitrogen balance can be controlled by the use of 
steroids (l6l) or by increased protein intake (162), the latter 
method being far more, preferable for these patients. The 
greatest concern for the use of thyroid hormone lies with the 
cardiovascular side effects. Palpitations, tachycardia, and 
increased blood pressure are common effects (158, 159, 151,157); 
cardiomegaly may occur (163) and angina pectoris has been re¬ 
ported in twenty per cent of one group studied (157). Urinary 
losses of calcium (164) may also be troublesome, possibly precip 
itating osteoporosis. 
In sum, thyroid hormone can be used in a dieting program to 
produce greater weight loss, is of doubtful benefit in the long¬ 
term maintenance of weight control, and is associated with a 
number of troublesome and potentially dangerous side effects. 
Consensus opinion (165) and recent review (160) conclude that 
the use of thyroid hormone in the obese ought to be limited to 
those patients found to be hypothyroid. However, Bray claims 
that thyroid hormone can be used effectively. Using 100 mg of 
triiodothyronine daily, he found an increased metabolic rate 
without the extent of the untoward effects found when 150 mg 
or more hormone have been used (158). A high protein diet can 
reduce the problem of nitrogen imbalance. 
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Other hormones have been used. Human chorionic gonadotropin 
(HCG) Has received some attention since Simeons first reported 
its use in 1954 (166). However, that study has been criti¬ 
cized and subsequent trials including double-blind studies found 
HCG to be of no benefit in weight reduction (167,168,169). 
Interest has been rekindled following a recent report by Asher 
and Harper who administered 125U of HCG by daily injections in 
dieting patients for six weeks and found a significantly greater 
weight loss in those patients than in a placebo control group 
(170). However, Hirsch and Van Itallie have challenged the 
conclusions of this study, noting that the HCG group received 
more injections than the control group due to a greater drop¬ 
out rate in the latter group. They reason that the HCG group 
may have benefitted from the placebo effect of greater injection 
therapy (171). Although the mechanism of action for HCG in 
weight reduction is undetermined, prevention of hunger, eleva¬ 
tion of mood (172), and thyroid stimulating activity (173» 17*0 
have all been postulated. The burden of proof remains to est¬ 
ablish the effectiveness of HCG, and, although it appears to be 
a safe agent thus far, its use should be considered experimental. 
Growth hormone (GH) is known to mobilize fatty acids, to 
deplete fat stores without significant nitrogen loss, and re¬ 
ported to have a calorigenic effect through increased oxygen 
consumption (175, 176, 143). These actions attract theoretical 
interest for the use of GH in obesity. bray administered 5 mg 
of GH daily to patients receiving tri-iodothyronine and found 

-53- 
oxygen consumption greater, nitrogen loss less, but weight 
loss slower than in the group receiving tri-iodthyronine without 
GM (l6l). Growth hormone appears to be well tolerated for short 
term usage, but long term safety (diabetogenic effect?) and 
effectiveness are undetermined. The present status of GH 
remains theoretical, as very limited supplies limit its use to 
restricted therapeutic trials (143). 
Finally, it should be mentioned that progesterone has 
been found to be of some benefit for the Pickwickian syndrome 
(177). The mechanism involved is not known, but believed to be 
related to pulmonary function, not weight (178). No longer used 
for weight reduction is the metabolic stimulant dinitrophenoi 
(DNP). This compound interrupts the coupling of oxidation and 
phosphorylation, causing generation and dissipation of heat 
rather than the formation of energy-rich phosphates. Use of DNP 
can raise the metabolic rate to about +$0fo and keep it at that 
level as long as the drug is continued. However, acute toxic 
effects related to hyperthermia are a hazard, as are a wide 
spectrum of untoward reactions associated with chronic admini¬ 
stration of DNP. Because of the high incidence of toxic reac¬ 
tions and abuse of DNP, the drug is no longer used for therapy(143). 
The use of drugs in the treatment of obesity remains of 
undramatic benefit. Amphetamines and thyroid hormones are the 
only agents that can be used reasonably in a weight reduction 
program. Utilized as adjuncts to a good diet, these agents must 
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be used with care in an individualized program that takes into 
account risks and benefits. Although there is some evidence 
that small dosages of thyroid hormone can potentiate the action 
of amphetamines (179*180), these studies are inconclusive becaus 
of the short duration of patient follow-up. Follow-up studies 
tend to indicate a somewhat favorable result of drug therapy 
as compared to only diet therapy when the follow-up time is 
short (181) and unfavorable results when follow-up time is 
longer.(182), The benefit of placebo effect need be antici¬ 
pated by the physician, and initial successes ought to be put 
in the context of treatment risk and long term benefits. 
Psychotherapy and Groups 
Hilde Bruch has pointed out that obesity is associated with 
a number of psychological disorders rather than one (14). In 
light of this and in understanding the complex non-psycholo- 
gical aspects of the etiology of obesity, the idea of a psycho¬ 
therapeutic cure for obesity seems unlikely. However, there is 
probably a group of patients in which emotional maladjustment 
is central to their obesity. Bruch has described in these pa¬ 
tients a positive relationship between food intake and conflict 
situations. The obesity may either be chronic, in which case 
it has become part of personality development, or may be acute, 
a reaction to a precipitating stress. A careful psychiatric 
and social history will often uncover associated emotional 
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problems. As mentioned before, a strong relationship between 
physician and patient can be of great therapeutic importance, 
and appropriate support, understanding, and firmness has 
psychotherapeutic value. More serious emotional problems may 
require considerable time and pschotherapeutic skills, necess¬ 
itating referral to the specialist. Often such patients are 
identified only after treatment failure or development of 
"dieting depression". (183). Psychotherapy is a therapeutic 
modality that some patients unequivocally refuse, while other 
more willing patients may find the expense difficult. The use 
of psychotropic drugs may be appropriate for some patients. 
Because this approach is so individualized, both diagnostically 
and therapeutically, analysis of results is not practical. 
Feinstein found psychotherapy and "mood elevation" successful 
for individualized cases, and possibly of benefit for mainten¬ 
ance (3). Clearly, some obese patients cannot successfully lose 
weight v/ithout adequate counseling and may in fact find dieting 
a severe upset to their emotional homeostasis. 
Of greater interest than individual psychotherapy in the 
treatment of simple obesity is group therapy. The effectiveness 
of group therapy-like methods is widely represented by the 
popular private lay organizations, the so-called self-help groups, 
that claim a high degree of success in treating obesity. Rigor¬ 
ous analysis of methods and results are scantily represented in 
the literature for these organizations. TOPS (Take Off Pounds 

-56- 
Sensibly), a non-profit group operating within a model not 
unlike Alcoholics Anonymous, and Weight Watchers, a commercial 
venture, are the largest of these organizations. A number of 
smaller groups exist, some of which have been transiently 
successful commercial ventures in recent years (184). 
Although the profit-making groups are generally unwilling 
to allow impartial researchers to study their results, there 
are several reports on the non-profit TOPS (185*186). Stunkard 
reported in 1970 that TOPS had well over a quarter of a million 
members in some 9500 chapters across the country. In his study 
of 485 members in 22 chapters in the Philadelphia area, he 
found membership to be comprised predominantly of white middle 
class women, aged 40 to 60, averaging about 60% above ideal 
body weight, and retaining active membership for an average 
l6| months. The results were impressive. 28% lost more than 20 
pounds, a figure that compares well with the medical litera¬ 
ture on weight reduction (2). When considering only the 5 most 
successful chapters, 50/6 lost at least 20 pounds, which is as 
good a result as the very best reports in the medical literature. 
The TOPS results also fared well when considered for 40 pound 
loss and by the criterion of reduction index (102). Follow-up 
reports are lacking, but one would expect that a treatment moda¬ 
lity that is social in nature, and realtively non-episodic in 
approach would stand a greater chance of long-term success 
than would many other methods. Questions remain, however, that 
make it difficult to interpret Stunkard*s results. Might not 
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this population be an unrepresentative group of obese indi¬ 
viduals, evidence by it being middle class, 99% female, and 
motivated enough to seek out the method (only yfo joined based 
upon physician's recommendation)? 
Other reports on the self-help groups have appeared. 
Failures were reported by Bowser, who found group therapy no 
better than non-treatment control in his subjects (187)# and 
Sussman, who reported a greater than 90% attrition rate over 
6 months within a group studied (188). Equally represented 
were a number of positive reports of group therapy (189»190). 
The fundamental aspect of the self-help approach is the 
use of social and peer group pressure to establish a positive 
attitude towards weight loss and a negative attitude towards 
rule-breaking and weight gain. By becoming part of the group 
(which usually meets weekly) a new social motivation to reduce 
is created. Often, the weigh-in opens each meeting in a highly 
ritualistic manner. Also important is the education and use of 
a planned but flexible diet that is rarely unduly harsh, allow¬ 
ing liberal amounts of food and emphasizing good food choice 
and reduced portions of richer foods. It allows the dieter to 
feel that he is not being calorically restricted (but of course, 
he is) and avoids the frequent association made between dieting 
and punishment. Discussion and sharing of relevant anecdotes 
can be useful, as motivation is intimately connected with group 
sharing and spirit. As a treatment for obesity, these groups 
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are less expensive than methods that require significant phy¬ 
sician time, and also have the appeal of offering a method for 
long-term weight control through establishing good dietary 
habits and attitudes. They should be among the physician's 
possible alternatives for the treatment of obesity. 
Behavior Modification 
One of the more promising methods for the treatment of 
obesity to gain recent attention not unrealated to the self- 
help groups is that of behavior modification. Based upon the 
basic psychological premise that views behavior in a stimulus- 
response model, behavior modifiers see obesity as the result 
of an eating disorder which can be behaviorally manipulated. 
Behaviorists look at the poor long term results of other obesity 
out-patient therapies (2) and conclude that diet and drugs fail 
because patients lapse back into their former habits (100). 
Obesity is viewed as an addictive behavior disorder, like al¬ 
coholism and drug addiction (97)» in which eating provides posi¬ 
tive reinforcement through good taste, hunger relief, and anx¬ 
iety or depression reduction. A number of behavior modification 
systems designed to reduce caloric intake have been described 
(191-197). In the medical community Albert Stunkard has emerged 
as the chief spokesman for behavior modification for obesity. 
He described this approach in four stages: 
1-Description of the behavior to be controlled. Daily 
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records by patients of amount, time, circumstances of eating: 
increased awareness of quantity, speed, environmental and 
psychological situations associated with eating. 
2- Modification and control of the discriminative stimuli 
governing eating. For example, time and places have become 
discriminative stimuli signaling eating. As in animal behavior, 
the stimuli come to "control" behavior. To decrease the potency 
of discriminative stimuli patients are encouraged to confine 
eating to one place (kitchen), to use distinctive table settings, 
and to make eating a "pure" experience (no other activities or 
distractions permitted.) 
3- Development of techniques to control the act of eating. 
Specific techniques to decrease eating speed, become aware of 
components of eating process, and gain control (e.g. counting 
mouthfuls, replacing utensils onto table after mouthfuls, 
deliberate interruptions). 
4- Prompt positive reinforcement of behaviors that delay or 
control eating. Reinforcement schedule, point system, money 
(as donations to altruistic cause). No berating for failure (183). 
This technique for the treatment of obesity was first 
reported in 1962 by Charles Ferster, a student of B. F. Skinner 
(198). Interest was lacking until 1967, when Richard Stuart's 
paper appeared (195). Over the next seven years, Stunkard claims 
about ten reports appeared in the literature. He notes:"...this 
field has grown up largely outside of medical purview and, at 
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times, in the face of medical oppostions." (183) Stuart, a 
social worker, used behavior modification over a year and re¬ 
ported a greater than 20 poung weight loss for all group mem¬ 
bers (195)• Although a small and uncontrolled study, the results 
are noteworthy in that they represent the best ever reported 
for outpatient treatment and by a method conducted by a man 
without any experience with obesity (183). Harris followed with 
a study using mildly obese college students, finding highly 
significant losses in the behavior modification group as com¬ 
pared to a control (19*0 » "but the study has been criticized 
for using as controls students who were told they were on the 
waiting list for treatment (183). Wollersheim’s study is 
better controlled. Using 79 mildly overweight female college 
students, 4 groups of 5 members each, experienced one group 
treatment modality: 1-focal behavior modification; 2-non-specific, 
insight oriented; 3-social pressure/self-help-like TOPS; 4-de- 
ferred treatment. Behavior modification was superior to control 
groups (197). Hagen, with a similar population, ran ten sessions 
for several months with a therapist-run behavior modification 
group, a leaderless bibliotherapy group in which a behavior modi¬ 
fication manual was used, and a deferred treatment control. 
The manual and group therapy members did equally well, averaging 
a 12 pound weght loss (199). 
Unlike the above studies, Stunkard's patients averaged 80% 
overweight (191). He compared the results of behavior modifica¬ 
tion groups led by young therapists who were leading such groups 
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for the first time, to matched groups led by an experienced 
clinician with extensive experience in the treatment of 
obesity, Dr. Sydnor Penick, who used traditional methods of 
supportive psychotherapy, instruction in dieting and nutrition, 
and, upon demand, appetite suppressants. Not only did the behav¬ 
ior modification groups do better after 12 weeks of treatment 
for both cohorts, but one year follow-up also showed that 
patients at least maintained their losses. It is noteworthy 
that Dr. Penick*s patients did impressively at one year follow-up. 
Percent of groups losing specified amounts of weight (from Stunkard) 
Weight 
Loss 
(lbs.) 
Behavior 
groups 
modification 
(No.=15) 
Control therapy 
groups (No.=17) 
Ave. in medi¬ 
cal literature 
at end of 
treatment (2) 
After 
treatment 
1-year 
follow-up 
After 
treatment 
1-year 
follow-up 
~74o~ 13 33 0 12 -n 
730 33 40 0 29 - 
720 53 53 24 47 25 
Recently, Brightwell summarized a behavior modification 
technique that he considered practical for the general physi¬ 
cian (200). He lists four criteria for patient selection: 
1- 10-100# overweight? 2-desire to lose weight; 3-motivation to 
participate over an extended period; 4—absence of emotional or 
physical contraindications to weight loss. He recommends five 
twenty minute sessions over two to three weeks, then one session 
per month for follow-up, and reports good results for his group. 
"Such programs help patients learn how to eat properly and sake 
responsibility for their intake". (200). Behavior modification 
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appears to be a superior outpatient method for weight reduction 
for the mildly and moderately obese. It is safe, relatively 
inexpensive and efficient, and in theory conducive to long 
term success. 
Massive Obesity and Radical Treatment Methods 
Based upon changing dietary habits, with or without the 
use of adjuncts, the reasonable treatment approaches discussed 
thus far, with the possible exception of thyroid hormone, ought 
to be viewed as relatively conservative in nature. Several 
radical weight reducing methods also exist. The appropriate use 
as opposed to potential misuse of these methods is among the 
most profound challenges in contemporary medicine. It is at thi 
point that the clinician must consider the entity of massive or 
morbid obesity as distinct from mild or moderate obesity. Patho 
physiologically such a distinction may seem artificial, but 
clinical realities call for this type of diagnostic maneuvering, 
even if dividing lines are admittedly somewhat arbitrary. Bray 
warns: 
Radical methods should be employed only in mas¬ 
sively obese patients who are severely handicapped 
or physically disabled by the excess weight, and 
only then after failure of all conservative 
treatment. (21) 
Craddock categorizes as intractably obese those patients 
whose obesity is "resistant to normal methods of treatment by 
diet and drugs". (29) He notes that this state is commonly 
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associated with compensatory eating and, simplistically, in a 
cycle of unhappiness/love lack->eats-^fat-*unhappiness. Em¬ 
phasizing the importance of uncovering patients’ reasons for 
overeating and attitudes towards dieting, Craddock states that 
depression should he appropriately treated. 
The morbidly obese patient has been defined as: 
...one who has reached two or three or more times 
his ideal weight, who has maintained this level for 
five years or more despite efforts by himself, 
his family, and his physician to bring about effec¬ 
tive and sustained reduction of weight to accept¬ 
able medical standards. (201) 
A less exacting criterion commonly used for morbid/massive 
obesity is weighing greater than 100 pounds above ideal v/eight. 
Refractoriness to nonradical methods may have more than a merely 
etiologic foundation. These methods can at best reverse caloric 
balance to the point of a maximum adipose tissue loss of about 
two pounds per week and probably less because of metabolic adapta 
tion in these patients. This rate of weight loss in a patient 
more than 100 pounds overweight is frustratingly slow and will 
rarely supply the positive feedback to maintain sufficient 
motivation to override the emotional and physical challenge of 
decreased eating. A recent editorial explains: "For the morbid¬ 
ly obese, 40 pounds is about the most weight that is lost and 
95$ of these patients will return to their previous or a higher 
weight within two years." (202). The following questions need 
be considered when evaluating the severity of obesity and appro- 
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priateness of radical therapy: 
1) How obese does the patient measure? 
2) How severe are the acute and chronic health con¬ 
sequences of the obesity? 
3) What are the chances of success of conservative 
treatment? (Consider weight and treatment history, psychosocial 
factors, motivation and interest). 
4) Do the benefits of reduction outweigh the risk 
of treatment? 
Fasting 
Physiologically, the concept of fasting is likely as old 
as that of diet. Anthropologically, the difference is great, as 
fasting since ancient to modern times has represented bodily 
self-sacrifice for some higher spiritual good. Willful starva¬ 
tion other than of the obsessional martyrdom type is seen by 
the medical community in patients, usually young women, with 
the bizarre eating disorder, anorexia nervosa. However, for the 
obese, fasting can maximize a negative caloric balance and 
has therefore been used therapeutically for obesity. 
Bloom first reported fasting as an introduction to obesity 
treatment in 1959* when he hospitalized nine patients and 
fasted them for four to nine days (203). After an average loss 
of 2.6pounds per day - greater than accountable based upon 
caloric deficit alone - these patients were put on low calorie 

-65- 
diets as outpatients. After two to nine months, follow-up 
results were satisfactory. Bloom emphasizes that the fast's 
benefit was largely in terms of patient education, his pa¬ 
tients learning that: 1-they could lose weight; 2-they did 
have will power; 3-food causes obesity; 4-they could tolerate 
a reducing diet; 5-th.ey could feel well when fasting. 
Keys had earlier described in his work on human starva¬ 
tion the absence of excessive hunger in fasting (204). The 
appeal of a treatment that dropped weight more quickly than 
dieting and could preclude the hunger problem began to at¬ 
tract other clinicians. In i960 Duncan fasted fifty intractably 
obese subjects for four of fourteen days, achieving an average 
daily weight loss of 2.5 pounds (205). Vitamins and fluids were 
given. He noted anorexia beginning after one day of fasting, 
proportional to ketonemia, and reports his patients had a sense 
of well-being while fasting. Also noting improved patient morale 
after the fast, he planned weight maintenance by using inter¬ 
mittent short fats to prevent relapse, allowing his patients 
to eat freely between fasts. 
Thomson reported that fasting could be effective and well 
tolerated for longer periods of time as in the case of one of 
his patients losing ninety-seven pounds in 236 days (206). He 
concluded that fasting is the treatment of choice for gross 
obesity. Eleven of Drenick’s patients fasted as outpatients 
for twelve to one hundred and seventeen days, registering an 
average daily loss of 0.91 pounds (207). These patients weighed 
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from 240 to 550 pounds and all had medical problems. Six 
stopped fasting before 25days because of side effects or 
choosing to drop out. The average loss was about 30 pounds, 
the greatest 116 pounds, and initial losses were rapid (up to 
nine pounds in one day) and found to be proportional to ini¬ 
tial weight. Drenick comments that the starvation v/as well- 
tolerated and contributed to these outpatients' eating habits 
in the future. 
Several follow-up studies help us to evaluate the long¬ 
term usefulness of fasting. Hunscher's large study followed up 
709 of Duncan's hospitalized fasted patients with a history 
of intractable obesity who were put on a reduced caloric diet 
and instructed to fast one day per week (208). Only 50% re¬ 
sponded to the follow-up inquiry and of those that did, 46% 
lost weight, 21% stayed the same, and 33% gained since hospi¬ 
tal discharge. The massively obese were among the most success¬ 
ful in the study. Hunscher concludes that two-thirds of the 
responders, known to be treatment failures, had benefitted from 
the fasting regimen. However, it would be unwise to assume 
that the 50% who did not respond did as well as the other 
group, and all that is knov/n is that 23% lost weight, and 33% 
did not gain weight. Also of note was that 58% of the re¬ 
sponders had follow-up durations of less than one year, where 
as 93% of the non-responders had follow-up periods greater 
than one year. Harrison followed-up 62 patients v/ho had had a 
hospital stay of 10 days (209). Of those one year post-fast, 40% 
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lost weight, while Zb% of the two year follow-up group had 
lost weight. Fifteen patients had been fasted more than once, 
but did not show significantly better results. McCuish's 
smaller study is more discouraging (210). Twenty-five patients 
greater than overweight with a history of treatment failure 
were followed-up a mean fourteen months after a successful 
inpatient fast for an average 25 days. All patients gained 
weight, the average amount of 28.5 pounds being slightly 
greater than the average amount lost by fasting. Because 
of these poor results, McCuish recommends using fasting only 
when some other medical reason necessitates it. 
Fasting has been considered a radical method for obesity 
treatment because it is nutritionally drastic. Numerous 
physiological changes have been noted in these therapeutical¬ 
ly starved patients, sometimes of significant clinical nature. 
Total starvation leads to an unavoidable protein depletion (21). 
Although not reported as a serious state, arrested hair growth, 
mild anemia and neutropenia as well as skin drying and scaling 
can occur. Ketonemia and ketonuria will occur, and can be 
used as a check for fasting adherence. Although usually mild, 
symptoms of unpleasant taste and nausea are not uncommon, and 
are thought by some to result in the hunger lack noted during 
fasting. The decreased hunger theory has been challenged, 
however, as Silverstone explains that what actually occurs 
is an increased hunger over the first fast day followed by a 
normal hunger state (211). Serum lactate levels may also be 
/ 
elevated and one case of fatal lactic acidosis during fasting 
has been reported (212). Besides protein loss, fluid losses 
can also be marked, particularly early in the fast. Ball 
determined that for a sixteen day fast less than ±5% of the 
weight loss was fat as compared to 70% when weight was lost 
by using a calorie-restricted diet (213). More prolonged fasts 
burn a greater percentage of fat, and analysis has determined 
that between 2000 and 2500 calories are lost per day (214). 
Reported weight losses for fasters reflect the effect of early 
fluid losses: 2.5 pounds average loss per day for short fasts 
(one to two weeks) (203*205*209) versus closer to one pound 
average loss for longer fasts (207,206,210). Fluid losses con¬ 
tribute to hypotension - orthostatic dizziness is a common 
minor problem-, decreased glomerular filtration (increased 
serum creatinine), and decreased hepatic perfusion (increased 
BSP retention and serum bilirubin) (21). 
Potassium depletion can also be a clinical danger, and sup¬ 
plementary potassium chloride is recommended (21). Magnesium, 
calcium, and phosphorous are also in negative balance, but the 
depletion seems to be insignificant. Hyperuricemia commonly 
occurs in which case allopurinol or probenecid can be used. 
Blood sugar usually declines slowly, and may be as low as 40mg^, 
but symptoms are not reported to have occurred (21). Vitamins 
are needed, and one case of Wernicke's encephalopathy has been 
reported (215). Other problems include lassitude and weakness, 
constipation and, for some, a psychological reaction to fasting. 
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Exercise should be limited, as weakness, orthostatic hypotension, 
and cardiac arrhythmias may occur. 
'TABLE 6* Recommended lie a ic at ions and Tests During 
prolonged Fasting. (From Bray (21) ) 
Routine 
Laxatives first 3 days 
Allopurinol 600 mg/day 
Vitamin and mineral capsule, l/day 
Folic acid, 5 mg/day 
Bicarbonate of soda, 1 g/day 
Potassium chloride solution (sugarless), 2 g/day 
As Necessary 
Calcium carbonate or antihistamines for nausea 
Mouthwash or calorie-free chewing gum for bad-taste 
Soluble bath oil for dry skin 
Tests 
Blood pressure, recumbent and upright, daily 
Urine acetone (ketone reagent strip), daily 
Serum creatinine, weekly 
Serum uric acid, weekly 
Bray recommends that fasting not be continued for more than 
two months, as some side effects are more evident as the star¬ 
vation is prolonged (21). Long-term effects from the metabolic 
changes of fasting are yet unknown. Contraindications to fast¬ 
ing mostly follow logically from the observed metabolic changes 
and the nutritional consequences of starvation: pregnancy, 
peptic ulcer, hepatic insuffiency, labile diabetes mellitus, 
gout or hyperuricemia. General mental and physical health must 
be considered, and the importance of heart disease is indicated 
by the report of two deaths in fasters with left ventricu¬ 
lar failure (216). Refeeding after fast is best gradual. Fluid 
retention may be marked, and a post-fast weight gain should 
be expected. Salt restriction may be beneficial. 
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It has been suggested that perhaps some of the metabolic 
derangements and dangers of fasting could be avoided with the 
use of a semi-starvation regimen. Genuth found a lessening 
of hypoglycemia, ketosis, hyperuricemia, and urinary losses 
of potassium and phosphorous by adding to the fast only 50 
grams per day of L-alanine, a glucose precursor (217). He also 
reports a persistence of anorexia when L-alanine, glucose, 
or casein calcium (milk protein) are used for 200 to 300 calories 
per day. In a program for 75 massively obese patients (average 
196$ ideal weight), Genuth followed a completely foodless week 
of hospitalization with a semistarvation regimen consisting of 
45 grams of casein calcium (Casec) and 30 grams of glucose 
daily for eight to fifty weeks as outpatients with close mon¬ 
itoring (218). Protein sparing through the use of small a- 
mounts of exogenous protein had been previously documented 
(219,220), and daily casein had been used in fasrers who con¬ 
tinued to lose weight but maintained nitrogen balance (220). 
60$ of Genuth's patients lost 40 pounds or more, the average 
loss being 85 pounds. Losses averaged about four pounds per 
week. 37/& of the patients were defined as failures: did not 
last eight weeks or did not average two pounds per week loss. 
Most failures had vague symptoms from the withdrawal of food. 
No severe chemical derangements occurred, and a modest cata¬ 
bolic state with small potassium and phosphorous losses did 
not prevent patients from having normal activities. Uric acid 
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and B-hydroxybutyrate elevations were measured but were well 
below fasting levels. 
Fasting is an effective method for relatively rapid weight 
loss. After careful initial screening to exclude those pa¬ 
tients for whom the physiologic stress of starvation would be 
dangerous, an inpatient fasting regimen can be well tolerated 
if close medical monitoring and appropriate preventive treat¬ 
ment are provided. Minor complaints are common, and life- 
threatening problems are uncommon but do occur. The contri¬ 
bution fasting makes to long-term obesity management is still 
uncertain, but most studies indicate modest long-term benefit 
for the intractably obese. Outpatient fasting as a method 
more reasonable than periodic inpatient fasting is not ideal 
because of the looser patient supervision and the marked fluid 
and protein shifts associated with the onset of fasting. Low 
protein/glucose semistarvation regimens appear promising and 
may prove useful and relatively safe for a segment of the mass¬ 
ively obese outpatient population that can comply with the 
freedom of an outpatient regimen. In sum, fasting may be 
indicated for the massively obese, the intractably obese, or the 
obese patient v/ho requires a rapid v/eight loss for medical 
reasons. It is of best use for rapid weight loss and of less 
clear benefit for long-term management. If time permits, apro- 
priate patients may be better treated with outpatient semi¬ 
starvation. As always, risks of this radical treatment must be 
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weighed against expected benefits. 
Surgery 
Obesity can be a chronic disorder, refractory to medical 
treatment, and particularly when massive, may be clearly 
life-threatening. Surgery as a last resort to produce a 
negative caloric balance and maintain v/eight control may be appro¬ 
priate for some patients as indicated by the opinion stated in a 
recent editorial: "There is no satisfactory nonoperative 
treatment for morbid obesity." (202). The intestinal bypass 
has been the surgical procedure to receive the greatest atten¬ 
tion, the basic principle being that of decreased nutrient 
absorption due to a surgically reduced intestinal absorp¬ 
tive surface. Kremen's experimental report of jejunoileostomy 
appeared in 195^ (221), and was soon followed by Payne's series 
of 90% bypass jejunocdtostomies (222). Although fine weight 
losses were achieved, the morbidity was prohibitive, as severe 
diarrhea, electrolyte abnormalities, and liver pathology v/ere 
seen and one death was reported. Reanastomosis in a second 
surgical procedure was recommended. By the mid - 60's the 
medical community had denounced the bypass as an unsafe approach 
to obesity (223). Nevertheless, some surgery continued to be 
done, reports appeared, experience was gained, and techniques 
improved (224 - 230). The jejunoileostomy emerged as the 
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best procedure, a less radical bypass that could achieve a 
balance between intake and weight loss v/ithout the need of a 
second surgical procedure. Recent articles estimate that about 
1000 cases have been published in more than two dozen series 
and the the total bypasses performed is probably several times 
this figure (229»230). The most popular procedure is that 
developed by Payne and DeWind (225) in which an end to side 
anastomosis is made between 14 inches of jejunum proximally 
and the last 4 inches of terminal ileum distally, allowing for 
some ileal absorption and leaving the ileo-cecal valve intact. 
The bypassed intestinal segment remains in situ closed at the 
jejunal end, and may be involved in the variable absorption 
seen, as a result of ileal reflux. Modifications have been 
developed with some good' results. The end to end jejunoil- 
eostomy is claimed theoretically good for lowering hyperlipidemia 
(225), and has also been reported to produce better weight loss 
than the end to side procedure (231). 
Postoperatively an adaptation period occurs in v/hich the 
remaining absorptive intestinal surface hypertrophies and weight 
eventually levels off at a point somewhat above the ideal. 
V/eight losses for the first year are generally reported to be 
between 85 and 100 pounds, greatest during the first six months, 
and proportional to the initial weight (231, 21, 229, 232). This 
represents about a 30% v/eight loss. Second year losses are 
reported to average about 50 pounds; third year average about 
25 pounds, and one study found an average nine pounds lost 
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during a fourth postoperative year (231). Buchwald averaged 
the weight losses reported in nine series and found jejunoileo- 
storny produced 35% weight loss (follow-up times varied, though) 
as compared to 4l% weight loss for a small series of jejunocolo- 
stomies (225). Salmon reports that two-thirds of his patients 
plateaued at weights within twenty pounds of ideal at one to 
three years follow-up (228), while Buchwald reports that 90% of 
his 94 patients reached within 50 pounds of their ideal weight 
(230). A few patients will not successfully lose an adequate 
amount, varying from one series to another (228,229). Bray notes 
that the weight loss in bypass patients is slightly slower than 
that achieved by fasting (21), 
The evident success in losing and maintaining weight for 
the massively obese patient with the intestinal bypass must be 
measured against the morbidity and mortality that results from 
this procedure. Operative and early postoperative mortality 
has been variously reported between 0.7% and 6% for a number 
of the larger series (225, 228, 230, 222, 202), as pulmonary 
emboli, cardiac failure, myocardial infarction, and wound in¬ 
fections are most commonly involved. Payne, who reports on 
I65 of his patients operated on over a 16 year span, found a 
total mortality of 9.7%, but only 6% that could be attri¬ 
buted to the bypass, with hepatic failure as the most common 
cause (222). 
The side effects of intestinal bypass are considerable. 
The average postoperative hospital stay was 10.5 days in one large 
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series, and non-fatal surgical complications of wound pro¬ 
blems, upper gastrointestinal bleed, urinary tract infection, 
pulmonary embolus, thrombophlebitis, and pneumonitis are re¬ 
ported in a minority of patients (230). Longer term effects 
experienced by nearly all patients include diarrhea, electrolyte 
abnormalities, and deficient vitamin B12 absorption. The diar¬ 
rhea tends to taper off after a 3 to 6 month period during 
which nearly every patient experiences the troublesome symptom, 
with up to 30 liquid stools per day reported (229). Related 
problems of anal pain, hemorrhoids, proctitis, and fissures 
can make this a difficult period. Salmon reports that 39% of 
his patients had diarrhea (3 liquid stools per day) at 6 months, 
25% at one year, and 13% at two years (228). Special diets 
can help, as can antidiarrheal agents. Although the diarrhea is 
usually controlled v/ith time, dietary indiscretion may cause 
recurrence. - Hypokalemia and hypocalcemia are frequent in the 
early postoperative period, when absorption is very low. One 
hypocalcemic death has been reported and another series reported 
hypocalcemic tetany in 3 of 140 cases (230). Prophylactic 
therapy using Lomotil, calcium carbonate, potassium, multi¬ 
vitamins, and B12 injections has been recommended (229). Fa¬ 
tigue, thirst, nausea, abdominal pain, and small gastrointes¬ 
tinal bleeds seen in the early postoperative period are usually 
well controlled. Hair loss occurs in about 3%» but recovery is 
after several months. 

A number of long-term complications exist. Of greatest 
interest has been the effect of bypass on the liver. Reports 
of hepatic failure and death (225) led to the conclusion that 
the bypass produces liver disease and is more hazardous than 
anticipated (233)« However, it was noted that it had previously 
been determined that liver function was abnormal in massive 
obesity (23^) and that 75% of the patients undergoing bypasses 
have fatty livers preoperatively (235)• Postoperatively, fat¬ 
ty changes are variable and unpredictable (222). A recent study 
reports that twelve of eighteen patients had an elevated SGOT 
and biopsy proven worsened fatty liver four months postopera¬ 
tively, and also showed amino acid deficiencies in a profile 
typical of protein-calorie malnutrition. Between 12 and 36 
months postoperatively weight stabilized, SGOT returned to nor¬ 
mal, hepatic fat diminished, and amino acids improved, all, 
presumedly, as a result of increased intestinal absorption (236). 
Post-operative amino acid supplementation is proposed as a 
means to protect the liver. Evidence supports the fact that 
after a period of postoperative challenge, the liver goes on 
to improve and may be improved from its preoperative state 
(237,236). 
Other long-term complications include those that can re¬ 
sult from the intestinal surgery: adhesions, obstruction, and 
rarely intussusception. Polyarthritis has been reported, and 
may be severe (230). As with fasting, gout and hypotension 
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may be precipitated. Other hazards include renal calculi, , 
gastric stress ulcers, duodenal ulcers, cholelithiasis, and a 
hyperchloremic acidosis with renal impairment. Intractable 
nausea and vomitting can be severe, leading to malnutrition and 
electrolyte imbalance. If a complication is severe enough and 
potentially reversible, reanastomosis may be indicated, as 
Payne found it necessary to reanastomose four of 153 jejunoileo- 
stomies because of intractable electrolyte imbalance and severe 
liver changes (231). 
The risks and ill effects of intestinal bypass are im¬ 
pressive. Indications and contraindications for this surgery 
are generally cautiously expressed v/ith this in mind. The 
following include criteria for surgery usually mentioned: 
1-massive obesity, usually of long duration; 2-a history of 
multi-treatment failure; 3-medical complications of obesity; 
4-emotional stability, cooperation, and motivation; 5-full 
informed consent. The last item is of great importance, as 
patients must understand what risks and responsibilities 
they are taking. An experienced and available medical and 
surgical team might be added to the criteria list, as the long¬ 
term responsibilities of the providers are considerable. 
Contraindications are relative, but in general reflect an 
attempt to protect the highest risk group from the hazards of 
the bypass. Often mentioned are liver abnormalities, advanced 
age, emotional instability, hostility, unwillingness to stop 
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all alcoholic intake, unrealistic expectations, and condi¬ 
tions that would be too risky for a major surgical procedure. 
The primary benefit of intestinal bypass is irreversible 
weight loss and weight control. Related benefits are decreased 
blood pressure (75%° preoperatively are hypertensive (230),) 
improved respiratory and cardiovascular function, limitation 
of diabetes mellitus (Q% preoperatively diabetic), improved 
arthritis, improved fertility, decreased serum cholesterol, 
and improved psychological situation. The weight loss is also 
beneficial against other obesity hazards that may now be pre¬ 
vented. Solow examined the psychological effects of intestinal 
bypass by studying 24 patients who had had the operation (238). 
Improvement in mood, self-esteem, interpersonal and vocation¬ 
al effectiveness, body image and activity levels were found, 
and the decrease in depression and improvements in ego strength 
were directly proportional to the magnitude of weight loss. 
Appropriate use of the intestinal bypass for obese patients 
is a great challenge. In making this decision the following 
questions may be helpful in the context of risk-benefit model: 
1- How obese is the patient? 
2- How great is the debilitation or risk caused by obesity? 
3- Have other methods been given an adequate trial? 
Is he a good candidate in terms of the physical and 
mental stresses of this procedure? 
4- 

There clearly seems to be a population of massively obese 
patients for which the intestinal bypass is the treatment of 
choice. It is, though, because of its high risks, the treatment 
of last resort. One recent concern expressed has been that 
i 
general surgeons will take this procedure lightly and perform 
too many (239)* This would be tragic. However, a good number 
of medical centers have the facilities, manpower, and profes¬ 
sional expertise to successfully integrate surgery, medicine 
and psychiatry into a team to work with bypass patients. To 
not ansv/er this therapeutic need would be a grave omission for 
a qualified medical center. 
Another surgical approach to obesity is that of gastric 
surgery. Either by gastroplasty or a gastric bypass that ex¬ 
cludes the distal 90% of the stomach, the small stomach reser¬ 
voir insures limited food intake through the deterrent of the 
dumping syndrome. Mason, who has had the greatest reported exper¬ 
ience with the gastric bypass, found weight losses for his pa¬ 
tients comparable to those found in the intestinal bypass 
literature, and with less mortality and morbidity (240, 241). 
The 4.6% overall mortality for the gastric bypass, however, is 
reduced to 2% for the gastroplasty, although the weight losses 
seem less reliable after the latter procedure. Fundamentally, 
the gastric procedure patients are less disabled than those with 
the intestinal bypass because the former only limits intake. 
\ 
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while the latter limits absorption (202). Although a less 
proven procedure, the gastric bypass or gastroplasty ought to 
be considered as an alternative to the intestinal bypass, and 
may be particularly useful for those massively obese patients 
for whom the malabsorptive side effects of the intestinal by¬ 
pass would be prohibitive. 
Numerous other treatment methods have been used for obesity. 
Those reviewed here, it was judged, represent the mainstream 
of the medical art of obesity therapy. Undoubtedly, other 
methods have often been used successfully if only infrequently. 
A new and novel method often has an appeal advantage over a 
more traditional one. Methods such as hypnosis and fad diets 
can be successful in the short-term but there is little evidence 
supporting their effectiveness for long-term weight control. (3) 
In addition to novel approaches that actually have some patho¬ 
physiologic basis, there are others that do not. Weight re¬ 
duction is a big business, and profit-seeking in this field is 
a strong incentive to push a reduction method or adjunct re¬ 
gardless of its proven effectiveness. Furthermore, obese pa¬ 
tients are often prime candidates for quackery when a personal 
history of failure exists and the physician-patient rapport 
has been tarnished. A physician can best protect his patients 
from quackery by maintaining an educating, sympathetic, and 
supportive role. 

Summary and Conclusions 
The definition, measurement, prevalence, hazards, cate¬ 
gorization, and etiology of obesity were reviewed in the 
previous section. It was concluded that obesity is a patholo¬ 
gical entity which is clinically measurable and carries with it 
distinct risks and consequences to one's physical, emotional, 
and social well-being. The risks and consequences are numer¬ 
ous and varied, are often of unclear connection to the obese 
state, and vary in reversibility resulting from weight reduction. 
Evidence favors the conclusion that weight reduction is desir¬ 
able for many and probably most obese individuals. The risks 
of obesity generally are proportional to the degree of adiposity, 
and weight loss can be urgently needed especially in massively 
obese patients and those with medical complications. 
As the etiology thus far determined is multiple and complex, 
it is not surprising that multiple therapeutic approaches would 
be available. The principles, methods, effectiveness, hazards, 
indications and contraindication for the treatments for obesity 
have been discussed in this section. Numerous approaches exist, 
reflecting the various etiologic influences, and differ, to 
some extent, in terms of short- and long- term effectiveness 
and hazards. All methods carry some risks and costs, varying 
in a spectrum from the most benign and conservative to the most 
radical. It has been stressed that because different treat¬ 
ment schemes are best applied to different patients, the physi- 

-82- 
cian should take a dynamic and flexible approach in which risks 
and consequences of nontreatment are comparatively considered 
against the risks, costs, and long- and short- term benefits 
of various treatment modalities. The following table may serve 
as a guide to quickly generalize the hazards and benefits of 
different treatments. 
TABLE 6 
TREATMENT ADVERSE RISKS AND 
CONSEQUENCES 
COSTS AND 
INCONVENIENCE 
SHORT TERM 
SUCCESS 
LONG TERN 
SUCCESS 
. ..... . _.. _ ^ V 0-5 )\ 
Low calorie 
diet 1 1 1 1 
Free diet 1 1 2 1 
Self-help groups 1 1-2 3 ?2 
Behavior modifi¬ 
cation 1 1-2 3 ?3 
Psychot herapy 1 3 l ?2 
Amphetamines/diet 2 2 2 1 
rhyroid/diet 3 2 3 1 
Fast 4 4 5 2 
Bypass 5 5 4 5 
The above chart is limited in usefulness in that it cannot 
take into account the specific case of the patient for whom 
treatment is being considered. Several points are worthy of 
further consideration. 
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AD VERSE RISKS AND CONSEQUENCES. Every treatment carries 
with it at least some risk, as the change in eating behavior 
required for even the most benign treatments can be a psycho¬ 
logical stress for some obese patients. If the patient for 
whom conservative treatment might precipitate a "dieting de¬ 
pression" can be identified during pre- or early treatment, 
then a decision not to treat such an obese individual might be 
appropriately made. 
COSTS AND INCONVENIENCE. A low calorie or free diet re¬ 
quires ongoing support and follow-up by a physician, nutritionist 
or other health care provider. If drugs are added to the program, 
both patient responsibility and physician/provider time may be 
increased. Self-help groups are generally less expensive on 
even a weekly basis than less frequent physician visits, and 
members often view the meetings as socially pleasurable rather 
than inconvenient. However, for some, an added dimension of 
compliance beyond just diet makes the self-help groups some¬ 
what more inconvenient. This is especially true for men, who 
rarely find these groups satisfying and effective. Behavior 
modification generally requires a leader's time - not necessarily 
a physician - with some understanding of the treatment method. 
However, bibliotherapy may prove to be an efficient alternative 
requiring a minimum of professional services. For the patient, 
it v/ould seem that compliance with behavior modification methods 
would be of moderate inconvenience. Psychotherapy is an ongoing 
procedure which is quite costly, in most cases. Fasting is 
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highly inconvenient and costly on an inpatient basis, but 
much less so if feasible as an outpatient. Surgical bypass 
is far greater in terms of cost and inconvenience than any 
other method. 
SHORT TERM SUCCESS. Individual successes vary, and the 
chart does not take into account, for example, the patient who 
will do better with the rigid guidelines of a strict low calorie 
diet as opposed to the more liberal approach of the self-help 
groups. The hysterical personality style may respond quite 
differently to a treatment approach than an obsessive-compulsive 
It is a challenge for the physician to provide a regimen for 
his patient that is sufficiently individually syntonic with 
his character, needs, and motivation to maximize chances for 
success. Furthermore, chances of success can be increased con¬ 
siderably by factors intrinsic to the physician-patient relation 
ship. These variable constant, evidence suggests that the short 
term success of the traditional conservative treatment methods 
(diets, amphetamines, psychotherapy) are generally poor to fair. 
The newer and less researched conservative mthods (self-help 
groups and behavior modification) are generally more promising. 
Only the fast and bypass have proven to be reliable methods for 
weight loss. 
LONG TERM SUCCESS. Of greatest importance in the treat¬ 
ment of obesity is the long-term success. Unfortunately, much 
less is known about the long-term effectiveness of different 
methods than the short-term success. While the latter is often 
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moderately good v/ith conservative methods, the former has 
traditionally been poor. Conservative methods that help 
change eating habits and behavior would seem to offer some 
advantages towards long-term weight control, but few studies 
have been conducted to verify this. There is little to lead 
one to suspect that fasting is especially effective in the 
long run. The only treatment for obesity known to be on long¬ 
term effectiveness is surgery. 
SUMMARY OF SUGGESTED TREATMENTS FOR PATIENTS OF VARYING DEGREES 
OF OBESITY 
Mild-moderate obesity 
(0-20^ overweight) 
1- Self-help grouos. If a quality organization exists in the 
community, this may be considered a first-line approach for 
women with mild to moderate obesity. Patient interest as a 
prerequisite, the physician ought to take the responsibility 
of patient follow-up and continued support so that another 
method can be used if this approach fails. Occasionally, men 
interested in these groups (such as Weight Watchers or TOPS) 
may be good candidates. 
2- Behavior modification. This newly utilized approach appears 
to be the treatment of choice for mild to moderate obesity. 
Unfortunately, the availability of this method for obese pa¬ 
tients remains very limited at this time. It is hoped that the 
resources will be rapidly developed so that patients can benefit 
from this promising approach to obesity. 
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3-Low calorie diet, A safe and simple approach, it may be 
effective with some patients, particularly those most motiv¬ 
ated, but usually is ineffective. Physician support is 
important. 
A—Free diets. Also safe and simple, some patients will do well, 
particularly those well-motivated and within the context of 
strong physician-patient rapport. Long-term management is 
generally poor. 
5- Amphetamines/diet. Anorexiants may be used as adjuncts for 
these patients, particularly to help a patient start a "dif¬ 
ficult" diet. Generally, these agents offer little above diet 
alone for long-term weight control. 
6- Psychotherapy, thyroid, fasting, surgery. These more hazard¬ 
ous and/or costly methods can rarely be justified to treat this 
group of obese patients. 
Moderate-severe obesity 
(20/-40/ overweight) 
1- Self-help groups. These groups may be effective for these 
patients, particularly women who have had previous success 
with them. 
2- Behavior modification. Although only several studies exist, 
behavior modification is probably the best first line treat¬ 
ment when available for this group of patients. 
3- Low calorie, or free diet. Few patients in this group will 
succeed on these regimens. Hov/ever, some highly motivated 
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patients may, and more hazardous treatments may prove unneces¬ 
sary. Recurrence is very high. 
4- Amphetamines/diet. Some patients may benefit from the grati¬ 
fication of more rapid weight loss that these drugs may con¬ 
tribute to, but for most patients, the benefit of adding 
amphetamines to a good diet regimen is marginal. 
5- Thyroid/diet. For carefully selected patients with close 
supervision, thyroid hormone may be used to contribute a 
successful weight loss. However, cessation of hormone treat¬ 
ment may lead to greater difficulty in maintaining the loss. 
o-Fasting. Inpatient starvation is severe treatment for these 
patients, but where rapid weight loss is strongly indicated, it 
may be necessary. Outpatient fasting or semistarvation is also 
rather severe, but could be well worthwhile for those patients 
for whom the above methods have failed, are contraindicated, or 
unavailable. 
7- Psychotherapy. This may be of great importance for certain 
patients for whom conservative treatment failure is evident 
and psychologic factors appear to be dominant. Unfortunately, 
both patient refusal and high cost of treatment often neces¬ 
sitate that this modality be underutilized. Of course, psycho¬ 
therapy is only an adjunct to a weight reduction method. 
8- Surgical bypass. This hazardous approach would rarely, if 
ever, be indicated for this population. 
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Severe obesity 
(k00/o-~60fo overweight) 
1- Solf-help groups, diets, amphetamines. Only occasionally will 
patients of this degree of obesity do well with these regimens. 
They require large weight losses for adequate treatment, and 
recurrence is likely. If treatment failure has not occurred 
in the past with these conservative methods, a treatment trial 
may be worthwhile with the hope that more radical methods may 
be avoided. However, most of these patients have a history of 
failure v/ith these methods. 
2- Behavior modification. There is some evidence that this 
approach may be effective for this group. Further experience 
will better resolve this issue, but at this point in time a 
trial of behavior modification could be worthwhile. 
3- Thyroid/diet. Although more hazardous than conservative 
measures, thyroid can be an effective adjunct to diet contri¬ 
buting to a successful weight loss. However, it has little or 
nothing to offer above more conservative methods for long-term 
weight control. 
4- Fasting. If conservative treatment methods fail, these patients 
ought to be considered for a period of supervised starvation 
or semistarvation. For most, a semistarvation trial (a pro¬ 
mising method by recent reports) would not be unreasonable. 
For many, including those for whom outpatient semistarvation 
is not successful, a supervised hospitalised fast should be 
tried with the hope that this successful weight loss will be 
maintained. 
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5- Psychotherapy. Counseling is probably indicated for most 
patients in this group with a history of treatment failure. 
Unfortunately, this is often not practical or possible. 
6- Surgical bypass. Surgery may be indicated for some patients 
in this group. Not only must their obesity be of sufficient 
severity and consequence to their well-being, but also a 
documented history over a period of years of treatment failure 
with conservative methods, fasting, and preferably, psycho¬ 
therapy. Of course, motivation and full informed consent are 
also prerequisites. 
Massive obesity 
(-> 60% overweight) 
1- Self-help groups, diets, amphetamines, thyroid. These treat¬ 
ments will only rarely be of significant benefit for the mas¬ 
sively obese. However, if conservative methods have not been 
tried, there is little to lose by initiating a trial for a 
limited period of time. Strong physician support is needed if 
a conservative method is to have any chance of success. Even 
if weight loss is achieved, recurrence is likely. 
2- Behavior modification. Evidence is lacking as to whether this 
method is of use for this group. However, since it is benign 
and early reports have been promising for its usefulness in the 
moderately obese, a trial may be worthwhile. 
3- Fasting. Fasting should be considered an indicated treatment 
for these patients after a history of treatment failure with 
more conservative measures. With the help of counseling and 
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support, and other learned means of weight control, it is hoped 
that surgery will not be necessary. 
4- Psychotherapy. Most of these patients could potentially 
benefit from the insight gained through this therapy. Psycho¬ 
therapy should be considered an important, if not necessary, 
adjunct to weight reduction therapy for the massively obese. 
Of course, some patients may refuse this therapy. 
5- Surgical bypass. This "last resort" treatment may be indicated 
in a fair proportion of the massively obese group. A history 
of treatment failure including conservative approaches, fasting, 
and psychotherapy should be documented, as well as a clear and 
serious health threat as a result of intractable massive obesity. 
Obesity, is a potentially treatable disorder that produces 
a variable but definite hazard to the health and well-being of 
an individual. The physician has the responsibility to devise 
a treatment program in conjunction with his obese patient that 
is in the best interest of the patient. Although successful 
treatment is difficult to achieve, particularly in the long 
run, a number of different treatment approaches can be used. 
Used appropriately in a conscientious program of ongoing com¬ 
mitment, the chances for successful treatment are maximized and, 
it is proposed, greater than that that has traditionally been 
achieved. 
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A FOLLOW-UP STUDY OF FASTED PATIENTS 
INTRODUCTION 
The treatment of obesity has been reviewed in the previous 
sections. It was concluded that simple obesity is a complex 
state resulting from a positive caloric balance but contributed 
to by multiple inputs. Likewise, a variety of treatment op- 
proaches are available that can be used to maximum effectiveness 
when a thorough knowledge of both patient and treatment method 
exist. Massive obesity, previously defined, poses a great chal¬ 
lenge to the physician as these unfortunate patients carry the 
greatest risks and consequences from their obese state and are 
usually refractory to conservative weight reduction methods. 
Fasting has developed as a major means of medical management 
for the intractable massively obese. As previously discussed, 
fasting has been in reported use for over fifteen years, during 

which time its effectiveness for rapid weight loss has been 
well documented. (203, 205-207). Used in a hospital setting 
with careful supervision, the fast is generally well-tolerated, 
although minor side effects are common, the nutritional state 
is drastic, and, rarely, life-threatening complications will 
occur (21, 212, 213, 215, 216). In a program in which patients 
are well-screened, inpatient monitoring appropriately executed, 
and preventive measures taken, most complications can be pre¬ 
vented or well-controlled. Although most fasts are terminated 
within two months, longer fasts have been reported and well- 
tolerated (21, 206), 
While the reliability of acute weight loss for hospitalized 
fasters is good, the benefit of fasting for long-term weight 
control is far less clear. Some authors have claimed that 
their fasted patients received benefit beyond the fasting weight 
loss in that positive feedback from a successful loss, changed 
eating habits, and the ease of not eating were important learned 
experiences contributing to long-term weight control (203, 205, 
207, 208). However, the few follow-up studies found in the 
literature show modes and inconsistent long-term weight control 
for those fasted (208-210). While the inpatient phase of weight 
loss is rather easily executed with consistent success, the out¬ 
patient post-fast period is far more variable in terms of pa¬ 
tient reponsiveness, appropriate treatment and the multitude of 
factors that can influence success. 
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This study follows up a group of thirteen patients who had 
been fasted for varying periods of time as inpatients on a meta¬ 
bolic research ward. In addition to information directly related 
to post-fast weight control, other issues related to the history, 
etiology, consequences, habits, hopes, expectations, knowledge 
and insight pertinent to obesity in these patients was explored. 
These results will be contrasted to our present understanding of 
the obese patient and his management. It is hoped that such in¬ 
formation can contribute to the successful management of obese 
patients on an individualized basis and also help illuminate 
important common characteristics of the severely obese. 
PATIENTS AND METHODS 
Thirteen patients had been fasted on a metabolic research 
ward at Yale-New Haven Hospital for varying lengths of time 
within the period from November 1973 to November 197^» All 
were under the care of Dr. Robert Sherwin, a metabolic fellow 
(under the supervision of Dr. Philip Felig) and later an assis¬ 
tant professor of medicine at the Yale Medical School. Patients 
were referred to Dr. Sherwin via several routes, and were 
screened by the following criteria: 1-rule out unhealthy 
(flexible), especially those with severe hypertension, heart 
disease, diabetes mellitus, or gout; 2-preferably young; 
3-preferable at least 50%> overweight; 4-motivated to lose v/eight 
by fasting. Prospective patients were to understand and consent 
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to an inpatient stay which included within it a fast and also 
metabolic studies requiring either ketone infusions that were 
to test the effects of ketone acids on urea nitrogen excretion 
and circulating amino acids or glucagon infusions that were to 
test the effects of fasting on glucagon kinetics. All patient 
costs were covered through research funds. After full informed 
consent, patients were admitted to a research ward which was 
predominantly filled with non-obese patients suffering from 
other ailments. Patients were first placed on a calorically 
controlled maintenance diet (generally 3000 calories) for 
various lengths of time, and then fasted with 0 calories for 
duration varying betv/een 17 and 70 days. One patient was calor¬ 
ically restricted for an extended period before fasting was 
begun. All admitted patients received complete histories and 
physical examinations. Electrolytes, calcium, phosphorous, 
magnesium, liver and renal function, protein, thyroid, and 
blood count were measured periodically. Patients were weighed 
daily. While fasting, patients were given daily 2 liters of 
water (minimum), multivitamins, 1 mg of folic acid, 625 mg 
sodium bicarbonate, intermittent potassium supplements as needed, 
allopurinal if hyperuricemic, and supplemental salt if ortho¬ 
static hypertension occurred. Patients were seen daily by 
Dr. Sherwin, who would spend on average about twenty minutes 
with each patient. Psychiatric consultation was sometimes 
used, and counseling (in addition to Dr. Shwerwin's role) was 
often recommended. Fasting was generally terminated when metabolic 

“95- 
studies were complete. Patients were then placed on a 150 to 
200 calorie diet and were gradually increased to a regimen of 
600 calories over a period varying from one to three weeks and 
then discharged. As outpatients,, patients were instructed to 
use diets generally between 600 and 1000 calories. Dr. Sherwin 
followed all these patients, seeing them on a flexible schedule 
of once per week or less frequently. 
All thirteen medical records were reviewed for data re¬ 
lated to the fasting hospitalization. Follow-up data was not 
consistently available in the medical record. With Dr. Sherwin’s 
cooperation, an attempt was made to plan an interview between 
each patient and the author at the Yale-New Haven Medical Center. 
Through a planned but flexible format of questions, the inter¬ 
view would explore relevant areas of weight and treatment history, 
the personal consequences of obesity, eating and exercise habits, 
the fasting experience, the follow-up period, and personal opin¬ 
ions and insights about the treatment of obesity and their weight 
problem. The length of the interview would vary between 45 and 
90 minutes. The research protocol was reviewed and accepted by 
the Yale Human Investigation Committee. An outline of questions 
covered in the interview appears in the appendix. 
RESULTS 
THE FAST AND FOLLOW-UP 
Medical records were reviewed for all thirteen patients 
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and data was collected for age, fasting dates, admission 
weight, pre- and post-fast weight, and hospital course. Follow¬ 
up data was available only through patients interviews of 
Dr. Sherwin's private records. Patients ranged between 19 and 
51 years of age, with a mean age of 31.6 . Eight were v/omen, 
v/ith an average weight of 251 pounds, and a range of 182 to 
350 pounds. Five men were fasted, averaging 463 pounds with a 
range of 310 to 655 pounds. The average weight for all 13 pa¬ 
tients was 308 pounds while the median was 264. The degree of 
obesity expressed as a percentage above maximum ideal weight v/as 
calculated. Using height and weight tables and assuming large 
frame body type the % overweight ranged from 20% to 206% with 
an average value of 88% and a median of 86%. Fasts ranged from 
17 to 70 days, v/ith a mean and median of 34.6 and 31.5 days 
respectively. The patient v/ho fasted 17 days terminated his 
fast by eating for several days while out of the hospital on 
pass. He returned to the hospital 20 pounds heavier and re¬ 
newed his fast for another 23 days. All other patients completed 
their fasts successfully, terminating according to physicain 
orders. Minor cheating episodes were occasionally reported, 
but did not seem to significantly affect weight loss rates. 
Patients v/ere frequently granted passes to leave the hospital 
when it v/as important for them to do so. Weight loss by fasting 
averaged 43.4, with a median of 40 and range of 20 to 71 pounds. 
The average loss per day v/as 1.27. Loss per day was calcu¬ 
lated to correlate with initial weight with an r value of 
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+ 0.64 (p< 0.05). (All computation schemes in appendix). 
The correlation between loss per day and days fasted calculated 
to r= -0.62 (p<0.02). All thirteen patients lost more than 
20 pounds, and 8/13 lost 40 or more pounds. Reduction indices 
ranged between 36 and 94, with a mean of 63 and a median of 66. 
Up to date follow-up data was available for 8 patients. 
For the five patients for whom current weights were not avail¬ 
able, a follow-up weight for their last physician visit was 
available for all but one. Follow-up duration ranged between 
0.and 15 months, with a mean of 7.1 and median of 8 months. 
Follow-up weight change ranged between 43 pounds lost to 255 
pounds gained, with a mean of 29.8 pounds gained and a median 
of 0 (no weight change). Expressed as a function of time, the 
monthly weight change ranged from 4.4 pounds lost to 23.2 
pounds gained, with a mean value of 4.2 pounds gained and a 
median of 0.3 pounds gained. Testing correlation between 
duration of follow-up and weight change (gain) for these 
patients, an r value of +0.47 was calculated (p<0.10). 
For the 8 patients with up-to-date follow-up data the mean 
follow-up interval is 8.3 months, the mean weight change is 
17*1 pounds gained and the mean monthly change is 2.1 pounds 
gained. 
Interviews were held with 8 of the 13 patients. All five 
of the non-interviewed patients are currently lost to Dr.Sherwin’s 
follow-up. Only one of the eight interviewed had stopped seeing 
him. No patients refused to be interviewed, but 5 were unable 
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to be located or reached. The mean duration of time from hos¬ 
pital discharge to the date of this study (interviews) is 
12 months for those not interviewed and 8 months for those 
interviewed. All of the following data was collected only 
from the 8 interviewed patients. 
Major reason for seeking treatment by fasting: health or 
physical problems -4, desperation -2, job requirement -1, 
self-satisfaction -1. 
Hopes and expectations for fast: 30 to 70 pound weight- 
loss -6, to successfully eat nothing -1, no expectations -1. 
3/8 of the patients mentioned continued weight loss after 
fasting as a major expectation. 
Fears of fasting: none-4, intravenous infusions -2, 
failure -1, regain of weight -1. 
General quality of fasting experience: easy or well- 
accepted -7, bad experience -1, The latter patient described 
the fast period as "one of the most difficult experiences 
in my life." 
Best aspect of fasting experience: weight loss and/or 
ability to lose weight -4, interactions with fellow obese 
patients -2, nothing -2. 
Worst aspects of fasting experience: emotional diffi¬ 
culties -4, boredom or confinement -5» physical difficulties -4. 
Of these latter 4 patients, 3 had some problem with orthostatic 
hypotension and 2 had muscle spasms after receiving a ketone 
infusion (1 of these patients had hyperventilated). Difficulty 
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coping with very ill or non-fasting patients on ward -3,, 
coping with forced regimen -1. 
Hunger: none -3» several days -3» one week -1, entire 
fast -1. 
Post-fast change in eating habits: none -3» slight -2, 
follows diet -1, can eat considerably less -2. 
Use of diet: poor or no adherence -3» moderate adherence 
(500 calorie) -1, generally good adherence (600-800 calories 
or free diet) -4, 
Frequency of medical follow-up: regular and at least once/ 
6weeks -4, irregular and rare -3, presently lost to follow-up -1. 
The average post-fast weight change for the four patients who 
regularly see their physician is -18.50 pounds. For the other 
four patients the average is +52.75 pounds. 
Purpose of follow-up visits: general support for weight 
control -5, check weight and diet -2, not sure -1. 
General satisfaction with fasting as treatment for obesity: 
yes - 6, no - 2. The most successful post-fast weight loser felt 
that the- fast was a good way to start a big weight reduction, 
proving to herself that she could lose weight and feel better. 
Two-patients felt that fasting was emotionally difficult. 
One faster criticized the method because it doesn't get to 
the root of the problem. "I can't fast my entire life," he said. 
WEIGHT HISTORY. 
Family: both parents obese -4, only one parent obese (mother) 
-4. 
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Obesity onset: infancy and early childhood -3» late 
childhood and early adolescence -2, late adolescence and 
early adulthood -3. 
Precipitating events for weight gain: emotional stress-7» 
Of these 7 patients 4 were able to specify important life 
events that preceded significant weight gain. Pregnancy -1, 
none -1. 
Pattern of weight change since onset: constant gradual 
gain -1, gradual gain with plateaus -2, gradual gain with marked 
spurts -2f gradual gain with intermittent losses -3. 
Previous treatments for obesity: low calorie or free 
diet -8, fad diets -3» psychiatric counseling -4, amphetamines-7, 
thyroid -1, Weight Watchers -4„ ? injection therapy -1, hypnosis 
-1, heat therapy -1, previous fast -2. 
Best treatment method experienced to date*, fast -6, free 
diet -1, Weight Watchers -1. 
Worst treatment method experienced: fast -4, amphetamines 
-2, low calorie diet -1, not sure -1. 
The ideal way to lose weight: a pill that burns up calories 
-3t don't know -3» stop eating -1, good habits/prevention -1. 
EATING AND EXERCISE HABITS. 
Number of regular meals per day: none-2, one -1, two -2, 
three -3. 
Quantity of intake: very large -4, moderately large -4. 
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Snacking habits; considerable snacking -8. 5 of these 
patients indentified the evening, one named the mid-afternoon, 
and two anytime as the periods during which they snacked the 
most. 
Food preference; none particularly -3* tasty and savory 
foods, not sweet or heavily spiced -4, sweets -1. 
Importance of eating habits for weight control; very 
important -6, moderately important -2. 
Are your habits conducive to weight gain?; yes - 8. 
Exercise amount; none-2, very little -5s moderate -1. 
Exercise enjoyment; dislikes -2, mixed feelings -4, 
likes -2. 
CONSEQUENCES OF OBESITY. 
Effects on social life and emotional well-being; public 
ostracism -4, self-image -2, job pressure -2, romantic life -2, 
compensatory personality development -2, affects entire life -1, 
no effects -1. 
Improvement of above effects after successful weight loss; 
yes -4, partial -3» no -1. 
Medical history relevant to obesity; mild or borderline 
hypertension -4, gall bladder disease -3» musculo-skeletal 
problems -3, respiratory difficulties -2, hyperuricemia -4, 
abnormal glucose tolerance -2, skin abcesses -2, phlebitis -1, 
menstrual irregularity -1, Cushing’s syndrome -1. 
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Improvement of health problems after successful weight 
loss: great improvement -1, some improvement -5» no change-2. 
Specific improvements appreciated by patients included respira¬ 
tory status, agility and mobility, and back pain. 
HOPES AND OPINIONS. 
Future treatment plans or expectations: fast -4, psych¬ 
iatric counseling -3f diet -4, exercise -1, s-urgical bypass -1. 
As one patient put it: "There is always the fear of putting 
it back on." 
Hopes for future: reduce to specific weight (235»210,235») 
140 pounds, or 85» 35s 35» and 0 pounds overweight respectively) 
-4? successfully reduce without specific goal -4. One patient 
responded: "when people will say ’You look good.’" 
Best possible treatment for obesity: fasting -2, fasting 
and diet -2, fasting plus psychiatric counseling and diet -2, 
individualized diet -2, ? surgical bypass -1. 
Understanding of surgical bypass for obesity: effective 
but risky -2, too drastic to be used -4, questionable effective¬ 
ness but risky -2. 
Source of knowledge about surgical bypass: physician(s)- 
4, literature and friends -4. 

DISCUSSION 
As has been decumented before, fasting is a highly effec¬ 
tive method for rapid weight reduction (203, 205, 206, 207s13)« 
The average weight loss of 43.4 pounds for these thirteen 
patients is considered successful by the criteria of 20 
or 40 pound loss or Feinstein's reduction index, for which 
he defined as successful a value of 60 or above (102), However, 
these criteria of success were developed before fasting emerged 
as an acceptable method for weight reduction in the severely 
obese and probably tend to overestimate the success of a fast. 
Fasts were generally terminated for these patients when the 
incidental metabolic studies were complete and, although an 
average reduction index of 63 was achieved, most patients were 
still considerably overweight and in serious need of further 
large weight loss. The goal of fasting is called into question 
here. The initial reported series of fasts were of short dura¬ 
tion, generally 2 weeks or less. Well tolerated, these fasts 
were viewed as beneficial not because of the magnitude of weight 
lost, but because they represented to patients a gratifying and 
successful running start on weight reduction and control (203, 
207). Later reports indicated that longer fasts could be well- 
tolerated with losses greater than 100 pounds (206, 207). 
Admittedly, the risks of malnutrition and metabolic derangements 
are increased by longer fasts, and Bray had advised that fasts 
longer than two months are usually unwise (13). 
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Daily fasting weight loss was proportional to initial 
weight ( r=+0.64, P<0.05)j as has been reported elsewhere (207). 
An inverse correlation existed between average daily loss and 
length of fast (r=-0.62, p<0.02)<i Fluid losses early in the 
fast contribute to the greater weight loss seen earlier in the 
fast (205). Reports from the literature average about 2.5 
pounds per day lost for short fasts (1 to 2 weeks), and closer 
to 1 pound per day for longer fasts (203? 205-207? 209, 210). 
The average loss per day for this series of 1.27 pounds over an 
average 34.6 days ( 5 weeks ) compares well with that reported 
in other series. That the fast was well tolerated and compliance 
generally good for these patients also is in agreement with pre¬ 
vious reports. 4 of 8 patients did describe the fast as emo¬ 
tionally difficult, and for one of these the fasting period was 
"one of the most difficult experiences of my life.". The need 
for screening out certain patients and/or strong psychiatric 
support during the fast is evident. Another patient commented 
that "psychiatry should be part of the program.". Innovation 
and change in the treatment setting and program could improve 
the quality of the fasting experience by specifically alleviating 
the stresses caused by boredom and confinement, and coping with 
very ill or non-fasting patients on the ward. Physical com¬ 
plaints were remarkably few, as the common side effects of 
orthostatic hypotension and electrolyte imbalances were well 
controlled medically* Hunger was a continued problem for only 1 
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of 8 patients, consistent with other reports. The hunger lack 
theory during fasting has been challenged, though (211). 
The uncertainty of the issue may be the result of the obese 
patient's difficulty in discerning physiologic cues relevant 
to his hunger and appetite control (88, 90). Indeed, it has 
been suggested that the obese are physiologically always hungry 
0-2). 
The duration of follow-up for these patients (mean =7.1 
months) is probably too short to consider as long-term. 
Bloom's original report followed-up his patients 2 to 9 months, 
finding that all maintained some of the fasted loss, and most 
maintained most of it (203). Hunscher's large follow-up study 
which included only 50% of the original patients - the others 
being lost to follow-up - found only one-third of the responders 
gained weight since hospitalisation (208). However, a total of 
two-thirds of the entire group may have gained if one considers 
those lost to follow-up as failures. Harrison's follow-up report 
found 40% of his 62 patients had lost weight 1 year post-fast, 
and 24/ showed loss after 2 years (209). McCuish's study was 
most discouraging, finding all his patients had gained weight 
after an average of 14 months of follow-up (210). In the present 
study, follow-up data was current for 7 of 13 patients, percent¬ 
age quite consistent with Hunscher's experience. However, 
retrospective follow-up data was available for 12 patients. 
4/12 regained all their lost weight, 2/12 regained some, and 
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6/12 lost weight since hospitalization. Again, this is 
remarkably similar to Hunscher's results. It was noted that 
the patients in this present study, like Harrison's and 
Hunscher's patients, tended to fare poorer as follow-up 
duration increased. Weight change correlated with follow-up 
results to appear less successful as the duration of follow-up 
increases. While only 2 of 8 patients felt their eating habits 
had been significantly changed since fasting, only 3 out of 8 
felt that the fast had no effect at all on their eating habits. 
Bloom and Drenick reported that their patients felt that they 
had benefitted in terms of improved eating habits (203). Only 
4/8 of the present group of patients have been able to success¬ 
fully use a diet after their fast. 6/8, though, were generally 
satisfied with fasting as a treatment method. Although most 
realized that fasting did not get to the root of their problem, 
they were still gratified by their experience with a method 
with which they were able to lose a considerable amount of weight. 
The usefulness of fasting in a long term weight reduction and 
control program for severely obese patients as evidenced by this 
study’s population remains limited. A few patients seem to have 
benefitted significantly, whereas they had not been successful 
with more conservative methods previously. Several patients, 
it would seem, did not benefit at all from the fast. Factors 
which influence success may be hypothesized based upon inter¬ 
view data, but the population studied is far too small from 
which to draw any conclusions. 
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A number of interesting patterns emerged from the inter¬ 
view data. These patients, with long and often life-time 
histories of obesity, coming from homes with obese parents, 
showed considerable insight into their condition. 7/8 could 
identify emotional stress as a major precipitant for weight 
gain. A/8 have had experience with psychiatric counseling. 
Patients v/ere also v/ell aware of the role that eating habits 
play in their obesity. All 8 could admit that their food in¬ 
take was large and snacking excessive. Nevertheless, their 
frustration was evident. One patient, who states that 
"insight helps," sadly admitted: "I’m addicted to food," and 
"I love food more than I love myself." Another disclosed, 
"I hate myself when I'm eating." What becomes clear is that 
what most of these very obese patients require is not so much 
advice, moralizing, or education about the basics of diet, 
but rather, support, understanding, and professional counseling. 
The patients were also aware of many of the consequences 
of their obesity. Most striking to them was the public ostra¬ 
cism. "People don't understand obesity," one patient stated. 
Another admitted that he felt a closeness to fat people, and 
that they were all going through the same thing. Another felt 
that there is little variation in obese people. The potential 
value of group discussion for these patients is evident. Most 
patients were also aware that their obesity had affected their 
character and emotions. Only one patient denied any effects 

-109- 
of obesity to his psychosocial well-being. Health effects 
were also noted. Half of these patients sought fasting be¬ 
cause of physical problems or fears. However, many of the 
effects were of the nature of chronic disease risk factors as 
opposed to present symptomatic difficulties. 
Unfortunately, only one patient felt great improvement of 
his problems as a result of experiencing weight reduction. 
However, most felt some improvement and would probably benefit 
more if more excess weight were lost. Most patients found 
the weight loss achieved through fasting as gratifying in a 
variety of ways. 
All these patients had a history of failure with other 
weight reduction methods. Diet and amphetamines stand out as 
the most frequently used unsuccessful methods. Two patients 
had had previous fasts and then regained the weight. Several 
patients had tried methods that have no sound basis for the 
treatment of obesity. It is noteworthy that 6 out of 8 pa¬ 
tients felt the fast was the best treatment they had exper¬ 
ienced, but that 4 of 8 patients also mentioned the fast as the 
worst treatment experienced. The success of the weight loss 
was undoubtedly gratifying for these patients, while the 
awareness that fasting may not be worthwhile in the long run 
also is present. Frustration is reflected in the responses to 
the fantasy question: "What would be the ideal way to lose 
weight, if it were possible?". Three patients were able to 
fantasize an energy burning pill, not too unlike the now 
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prohibited agent dinitrophenol (143). Three others were 
unable to imagine any ideal treatment. Concerning the 
surgical bypass, 6/8 had negative attitudes. Physicians, 
particularly non-surgeons, often have strong prejudices 
against risky surgical procedures. Evidence strongly favors 
that surgical, bypass can be used effectively in properly 
selected massively obese patients (13, 22?~232, 239). To 
pass on a contrary opinion to patients is not fair, as it would 
be equally inappropriate to lead a patient to believe that such 
surgery is v/ithout considerable risks and side effects. 
All patients expressed hope to be able to reduce. Some 
set specific goals which were to a variable degree above their 
maximum ideal weight. 4/8 expected to fast again if need be 
in the future, 4/8 expected to rely on diet, and 3/8 mentioned 
the use of psychiatric counseling. 
The information gathered through the interviews, while 
not sufficient in this small group to draw significant specific 
conclusions, does tell us a great deal about the very obese 
patient. He is generally an individual who has lived with 
obesity, treatments, and consequences for a long time, and has 
some insight into and considerable awareness of the behavioral 
aspects and consequences of his obese state. Despite all his 
experience, he is frustrated by the elusiveness of success. 
Several themes emerged that are relevant to specific treatment 
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methods: 
1 - Many of these patients are excellent candidates for psy¬ 
chiatric counseling. They come motivated and with a modicum 
of insight into their problem. 
2 - Many of these patients are reasonable candidates for 
behavior modification. They are motivated and aware of their 
bad eating habits and its importance in obesity. Although 
the efficacy of behavior modification for patients this obese 
is still not sufficiently proven, Stunkard's study is promising 
(191), and a trial for these patients would seem worthwhile. 
3 - Many of these patients could benefit from group therapy. 
The burdens of obesity are considerable, and the group process 
offers patients a unique support system that often cannot be 
reproduced by an individual therapist. 
4 - For most of these patients fasting was generally a gra¬ 
tifying experience. While they tend to desire refasting to 
achieve a rapid weight loss, they also realize that the fast 
alone often does little to insure long-term successful weight 
control. If recurrence occurs, or another major weight loss 
is needed, outpatient semistarvation as described by Genuth (218) 
is a promising and relatively safe method that could be worth¬ 
while for these patients. 
Data about the fast and follow-up tend to support that 
which has emerged as a consensus from the medical literature: 
Fasting is effective for rapid weight reduction and is well 
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tolerated with side effects and metabolic derangements well 
controllable. While most patients will not do well in terms 
of long-term weight control, some seem to benefit considerably 
whereas previous conservative methods had failed. Fasting has 
an appropriate place in the spectrum of treatment for the 
extremely or massively obese patient. It ordinarily ought to 
be utilized after less radical methods have been given a fair 
trial and proven ineffective, and usually in conjunction with 
professional counseling or supportive therapy to maximize suc¬ 
cess. If fasting proves ineffective in controlling massive 
obesity, alternative methods need be considered, including 
surgical bypass. A thorough understanding of an obese patient's 
weight history and experience, insights, feelings, and opinions 
about obesity and treatment can contribute to the planning of 
an appropriate and effective weight control program. 

APPENDIX 
IC OUTLINE OF INTERVIEW 
I. Introduction - greeting and explanation of project 
II. History 
A. General medical 
B. Obesity 
1. family: "Have other members of your family been 
overweight?" 
2. onset and precipitating factors: "When do you 
first recall becoming overweight? Can you recall 
things that happened in your life that preceded 
or somehow caused you to eat more or gain weight?" 
3. course - weight chronological history 
4. Treatments - successes, failures, opinions: "What 
method for losing weight has been best for you?... 
Why? Which methods didn't work?...Why? What 
would be an ideal way to be able to lose weight 
if it were possible?" 
5. consequences 
a. social: "Do you think being heavy has effected 
your social life?...How?...Any different after 
weight loss?" 
b. psychological: "Has being overweight effected 
your personality?... Your feelings?... Your 
mood?...Your behavior? Any different after 
weight loss?" 
c. medical: "How has being heavy effected your 
health? Any change after weight loss?" 
6. eating habits 
a. Meals - #f quantity, time, dieting, snacks 
b. foods - preferences 
c. insights: "Do you think eating habits are 
important in maintaining or changing weight? 
Are your eating habits conducive to main¬ 
taining or losing weight?...Why (not)?" 
7. excercise - amount, frequency, pleasure derived 
III. Fasting experience 
A. Motives and expectations: "Why did you accept this 
treatment? V/hat were your hopes and expectations 
of its success?... Any Fears?" 
B. Feelings, opinions about fasting experience: "How 
did you feel about fasting once you had started? 
...Like or dislike?... What and why?...Any hunger?" 
C. Results - short and long term 
1. post treatment course --- present: weight 
2. eating habits, diet adherence: "Any change in 
eating habits? Are you using a diet?...Which? 
...Stick to it?" 
3. medical follow-up: "Have you been seeing a doctor 
about your weight or health since you left the 
hospital?... How often?... What does he do or tell you?" 
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IV. "Prognostics" 
A. General satisfaction with fast as treatment; "Are you 
satisfied with fasting as a method by which you can 
lose or control your weighs?" 
B. Plans for future treatment:"Do you expect to undergo 
a weight reducing regimen again? Which Method?... Why?" 
C. Hopes 
1. Weight problem - the future?: "Do you think weight 
will be a problem for you in the future? Why?" 
2. Best treatment: "In your opinion, what is the best 
treatment for overweighs, including diet, exer¬ 
cise, medicine (pills), surgery, or any other 
method?.,.Why?" 
3. "What do you think or know about surgery for con¬ 
trolling weight? How did you learn this?" 
V. Closing 
A. Questions? 
B. Thanks and well wishes 
TT7 Correlation between average daily weight loss and initial weight 
Simple linear correlation was sested, using the formula for 
the Pearson product-moment, correlation coefficient, r, where-"- 
/ 
Zxy 
(Mlv' 1± 
(£x)a' (yv z _ (£y)aN 
n n ‘ 
where: x = average daily v/eight loss 
y = initial weight 
n = fasted patients 
Probability was tested for a s value, where: 
t = r 
1.1 J , Correlation between average daily weight loss and number 
of days fasted. 
r coefficient calculated as above, where: 
x = average daily weight loss 
y = number of days fascsd 
n = fasted patients 
t and probability calculated as above. 
IT. Correlation between duration of follow-up and weight change 
since hospitalization. 
r coefficient calculated as above, where: 
x = duration of follow-up in months 
y = change of weight ir. pounds since hospitalization 
n = fasted patients wish follow-up history 
^Formula from J. Ipsen, P. Feigl: Bancrofts Introduction to 
Biostatistics, New York, Harper, 
— — 1970. 

-115- 
REFERENCES 
1. Letter: The enigma of obesity. Lancet 1:133, 1974. 
2. Stunkard AJ, McLaren-Hume M: The results of treatment for 
obesity. Arch Intern Tied 103:79, 1059* 
3. Feinstein AR: The treatment of obesity: an analysis of 
methods, results, and factors which influence success. 
J Chr Dis 11:349, I960. 
4. Mayer J: Overweight: causes, cost, and control, Prentice 
Hall, Inc., Englewood Cliffs, NJ, 19&8 
5. Bray GA: The varieties of obesity, in GA Gray and 
JE Bethune, eds. , Treatment And Management of Obesity 
.sNew York, Harper and Row, 19747 
6. Random House Dictionary, New York, Random House, 1966. 
7. Stedman’s Medical Dictionary, 21st Ed., Baltimore, Wil- 
liams and Wilkins, i960. 
8. Mayer J: Obesity, in RS Goodhard. and M Shils, eds., Modern 
Nutrition in Health and Disease, Phila., Lea and Febiger, 
1973. 
9. Salans LB: Cellularity of adipose tissue, in GA Bray and JE 
Bethune, eds., Treatment and Management of Obesity, New 
York, Harper and Row/-!974. 
10. Forbes GB, Reina JC: Adult lean body mass declines with age: 
Some longitudinal observations. F/letabolism 19: 653, 1970. 
11. Powley TL, Keesey R.: Relationships of body weight to the 
lateral hypothalamic feeding syndrome. J. Comp Physiol 
Psychol 70:25, 1970. 
12. Nisbett RE: Starvation and the behavior of the obese, in 
GA Bray and JE Bethune, eds., Treatment and Management 
of Obesity, New York, Harper and Row’, 1974. 
13. Bray FA: Obesity: A serious symptom. Ann Intern Med 77:5, 
1972 
14. Bruch H: Psychiatric aspects of obesity. Metabolism 6:461, 
1957 
15* Seltzer CC, Mayer J: A criterion of obesity. Postgrad Med 
38:A101, 1965. 

-116- 
16. Keys A, Fidanza F, Karvonen MJ, et al,: Indices of relative 
weight and obesity. J Chronic Dis 25:329, 1972. 
17. Metropolitan Life Insurance Company: Statistical Bulletin 
#40, I960 ..... ” ‘ 
18. Blackburn H, Parlin RW: Antecedents of disease, insurance 
mortality experience. Ann NY Acad Sci 13^:965, 1966. 
19* Sheldon WH: An Atlas of Man, New York, Harper, 1954. 
20. Seltzer CC, Mayer J: Body build and obesity - who are the 
obese. JAMA 189:637, 1964. 
21. Bray GA: Obesity: A serious symptom. Ann Int Med 77:5, 1972. 
22. Build and Blood Pressure Study, Chicago, Society of Actuaries, 
1959. 
23. Silverstone JT, Solomon T: The long term management of obesity 
in general practice. Br J Clin Pract 19:305, 1965. 
24. Hendry DWW: Presymptomatic screening. J R Coll Gen Pract 
16:45, 1968. 
25. McMullen JJ: Obesity and body weight in general practice. 
Practitioner 182:222, 1959. 
26. Densen PM, Ullman DB, Jones EW, et al.: Childhood character¬ 
istics as indicators of adult health status: relationship 
of school records to selective service classification. 
Pub Health Rep 85:981, 1970. 
27. Mann GV: The influence of obesity on health. NEJM 291*415, 
1974. 
28. Obesity and Health (A Sourcebook of Current Information for 
Professional Health" Personnel)” USPHS Division of Chronic 
Disease, PH3 Pub No. 1485, Wash. D.C., US Government 
Printing Office, 1966. 
29. Craddock D: Obesity and Its Management, London, E & S Living¬ 
stone LTD.l 1969T"”- 
30. Mann GY: Obesity, the nutritional spook. Am J Pub Health 
61"1491, 1971. 
Petit DW: The ills of the obese, in GA Bray and JE Bethune, 
eds., Treatment and Management of Obesity, New York, 
Harper and Row, 1974. 
31. 

-117- 
32. Mortality Among; Overweight Women, Statistical Bulletin, 
Metropolitan Life Insurance Company, 4l:2, i960. 
33* Nisbett RE: Taste, depreciation, and weight determination 
of eating behavior. Pers Soc Psychol 10:107, 1968. 
34. Feinberg GL: Obesity: Class IV Anesthesia risk. NY State 
J Med 71:2200, 1971, 
35* Wilmore DW, Pruitt FA: Fat Boys get burned. Lancet 2:631,1972. 
36. Kannel WB, Brand PI, Skinner JJ, et al.: Relation of adiposity 
to blood pressure and development of hypertension: 
Framingham Study. Ann Int Med 67:48, 1967. 
37. Marks HH: Influence of obesity of morbidity and mortality.. 
Bull NY Acad Med 36:296, i960. 
38. Pincherle G, Wright H: Screening In the early diagnosis and 
prevention of cardiovascular disease. J Coll Gen Pract 
13:280, 1967. 
39* Alexander JK: Chronic heart disease due to obesity. J Chron 
DIs 18:895, 1965. 
40. Epstein FH, Francis T Jr., Hayner NS, et al,: Prevalence of 
chronic diseases and distribution of selected physiologic 
variables in a total community: Tecumseh, Michigan. 
Am J Epid 81:307, 1965. 
41. Me Donough JR, Garrison GE, Hames CG: Blood pressure and 
hypertension disease among negroes and whites in Evans 
County, Georgia, in J and R Stamler, TN Pullman, eds., 
The Epidemiology of Hypertension, NY, Grune and Stratton, 
1967. ~ 
42. Whyte HM: Blood Pressure and Obesity. Circulation 19:511,1959. 
43. Kannel WB, LeBauer EJ, Dawber TR, McNamara PM: Relation of 
body weight to development of coronary heart disease: 
Framingham Study. Circulation 35:734, 1967. 
44. Keys A: Coronary heart disease: Overweight and obesity as 
risk factors. Ann Int Med 77:15, 1972. 
45. Chapman JM, Coulson AH, Clark VA, et al.: The differential 
effect of serum cholesterol, blood pressure and weight 
on the Incidence of myocardial infarction and angina 
pectoris. J Chron Dis 23:631, 1971. 

-118- 
46. Paffenbarger RS Jr, Wolf PA, Notkins J, et al.: Chronic dis¬ 
ease in former college students. I. Early precursors of 
fatal coronary heart disease. Am J Epid 83:314, 1966. 
47. Montoye HJ, Epstein FH, Knelsberg MO: Relationship between 
serum cholesterol and body fatness. Am J Clin Nutr 
18:397, 1966. 
48. Walker WJ, Lawry EY, Love DE, et al.: Effect of weight 
reduction and caloric balance on serum lipoprotein and 
cholesterol levels. Am J Med 14:654, 1953* 
49. Wintrobe MM, Thorn GW, Adams RD, et al., eds., Harrison * s 
Principles of Internal Medicine, 6th Edition, NY, 
McGraw-Hill, 1970. 
50. Chirico AM, Stunkard AJ: Physical activity and human obesity. 
NEJM 263:935, I960. 
51. Bullen BA,, Reed RB, Mayer J: Physical activity of obese and 
nonobese adolescent girls appraised by motion picture 
sampling. AM J Clin Nutr 14:211, 1964. 
52. Mayer J, Roy P, Mitra RP: Relation between caloric intake, 
body weight and physical work. Am J Clin Nutr 4:169,1956 
53. Beaudoin R, Van Itallie TB, Mayer J: Carbohydrate metabolism 
in 'active* and'static* obesity. J Clin Nutr 1:91,1953* 
54. Bray GA: Effect of caloric restriction on energy expenditure 
in obese patients. Lancet 2:397, 1969. 
55* Sims EAH: Studies in human hyperphagia, in GA Bray and JE 
Bethune, eds., Treatment and Management of Obesity, New 
York, Harper and Row, 1^47"” 
56. Sims EAH, Goldman RF, Bluck CM, et al.: Experimental obesity 
in man. Trans Assoc Am Physicians 81:153, 1968. 
57. Sims EAH, Horton ESr Salans LB: Inducible metabolic abnor¬ 
malities during development of obesity. Ann Rev Med 
22:235, 1971* 
58. McCay CM: Effect of restricted feeding upon aging and chronic 
diseases in rats and dogs. Am J Pub Health 37:521, 194?* 
59. Johnson ML, Burke BS, Mayer J: Relative importance of inactiv¬ 
ity and overeating on the energy balance of obese high 
school girls. Am J Clin Nutr 4:37, 1956. 

-119- 
60. Bloom WL, Eidex MF: Inactivity as a major factor in adult 
obesity. Metabolism 16:679, 1967. 
61. Dorris FJ, Stunkard AJ: Physiological activity, performance 
and attitudes of a group of obese women. Am J Med Sci 
233:622, 1957. 
62. Moore ME, Stunkard AJ, Srole L: Obesity, social class, and 
mental illness. JAMA 181:962, 1962. 
63. Caufman WJ, Pauley WG: Obesity and emotional status. Penn 
Med J 64:505, 1961. 
64. Stunkard AJ, Rush J: Dieting and depression reexamined. 
Ann Int Med 81:526, 1974. 
65. Bruch H: The Importance of Overweight, New York, Norton, 1957« 
66. Simon RIs Obesity as a depressive equivalent. JAMA 183:208, 
1963 
67. Weisinger JR, Kempson RL, Eldridge FL, et al.: The nephrotic 
syndrome: A complication of massive obesity. Ann. Int 
Med 81:440, 1974. 
68. Bray GA, York D: Genetically transmitted obesity in rodents. 
Physiol Rev 51:598, 1971. 
69. Newman HH, Freeman FN, Hollzinger KJ: Twins- A Study of 
Heredity and Environment, Chicago, Univ. Chic. Press,1937* 
70. Shields J: Monozygotic Twins Brought Up Apart and Brought 
Up Together, London, Oxford Press, 19b2 
71. Davenport H: Body Build and its Inheritance, Wash,, D.C., 
Carnegie Institute, 1923. 
72. Bjorntorp P, Sjostrom L: Number and size of adipose tissue 
fat cells In relation to metabolism in human obesity. 
Metabolism 20:703» 1971. 
73. Bray GA: Measurement of subcutaneous fat cells from obese 
patients. Ann Intern Med 73:565» 1970. 
74. Hirsch J, Knittle JL: Cellular!ty of obese and nonobese 
human adipose tissue. Fed Proc 29:1516, 1970, 
75* Salans LB, Cushman SW, Weissman RE: Studies of human adi¬ 
pose tissue: Adipose cell size and number in nonobese 
and obese patients. J Clin Invest 52:929» 1973. 

-120- 
76. Salans LB, Horton ES, Sims EAHs Experimental obesity in man: 
Cellular character of the adipose tissue. N Clin Invest 
50-1005, 1971. 
77. Knittle JL, Hirsch J: Effect of early nutrition on the devel¬ 
opment of rat epididymal fat pads: cellularity and metab¬ 
olism. J Clin Invest 47:2091, 1968. 
78. Jariov E: The clinical types of abnormal obesity. Acta Med 
Scand 42:1, 1932. 
79. Mayer J: Genetic, traumatic and environmental factors in the 
etiology of obesity. Physiol Rev 33:472, 1953. 
80. Bjurlf P: Atherosclerosis and body-build with special refer¬ 
ence to size and number of subcutaneous fat cells. Acta 
Med Scand (Suppl 349), 1959* 
81. Kavlie H, White TT: Pancreatic islet beta cell tumors and 
hyperplasia. Experience in 14 Seattle hospitals, Ann 
Surg 175:326, 1972. 
82. Durwin JVD, Passmore R: Energy, Work, and Leisure, London, 
Heinemann, 1967. 
83. Passmore R, Meiklejohn AP, Dewar AD: Energy utilisation in 
overfed thin young men. Mr J Nutr 9:20, 1955- 
84. Passmore R, Strong JA, Swindells YE, El Din N: The effect of 
overfeeding on two fat young women. Br J Nutr 17:373, 1963. 
85. Miller DS, Mumford P, Stock MJ: Gluttony: Thermogenesis in 
overeating man. Am J Clin Nutr 20:1223, 1967. 
86. Gallon DJ: An enzymatic defect in a group of obese patients. 
Br Med J 1:1498, 1966. 
87. Goldzieher ZW, Green JA: The polycystic ovary I. Clinical and 
histologic features. J Clin Endocrin Metab 22:325,1962. 
88. Schacter S: Some extraordinary facts about obese humans and 
rats. Am Psychol 26:129, 1971. 
89. Nisbett RE: Eating behavior and obesity in men and animals. 
Adv Psychosom Med 7:172, 1972. 
Schacter S, Goldman R, Gordon As Effects of fear, food depriv¬ 
ation and obesity on eating. J Pers Soc Psychol 10:107, 
1968. 
90. 

-la - 
91. Gordon ES: Metabolic aspects of obesity* in R Levine and R 
Left, eds., Advances in Metabolic Disorders, New York, 
Academic Press, 1970. 
92. Mayer J. Marshall NB, Vitale JJ, Christensen JH, Mashayekhi 
MB, Sture FJ: Exercise, food intake and body weight in 
normal rats and genetically obese adult rats. Am J 
Physiol 177:544, 195^. 
93. Shipman WG, Plesset MR: Anxiety and depression in obese 
dieters, Arch Gen Psych 8:530, 1963. 
94. Yudkin J: The causes and cure of obesity. Lancet 2:1135,1959. 
95. Silverstone JT: Psychosocial aspects of obesity. Proc R Soc 
Med 61:371, 1968. 
96. Stunkard AJ, Mendelson N: Disturbances in body image of 
some obese persons. J Am Diet Assoc 38:328, 1961. 
97* Bloom WL, Clarke WB: The obese carboholic. J Obesity 1:10,1964. 
98. Goldblatt PE, Moore ME, Stunkard AJ: Social Factors in 
obesity. JAMA 192:1039, 1965. 
99. Mann GV: Obesity, the nutritional spook. Am J Pub Health 
61:1491, 1971. 
100. Musante GJ: Obesity: A behavioral treatment program. Am 
Fam Prac pp. 95, December 197^. 
101. Feinstein AR: The problem of treatment in obesity. Gen 
Prac 23:83, 1961. 
102. Feinstein AR: The measurement of success in weight reduc¬ 
tion: An analysis of methods and a new index. J Chron 
Dis, Nov. 1959. 
103. Gwinup G: Effects of diet and exercise in the treatment of 
obesity, in GA Bray and JE Bethune, eds., Treatment 
and Management of Obesity, New York, Harper and Row,1974. 
104. Bortz WM: Predictability of weight loss. JAMA 204:101,1968. 
105. Strang JM: in GG Duncan, ed., Inherited Diseases of Metab¬ 
olism, 5th edition, Phila., Saunders, 1964 
106. Kotilanen M: Group therapy for obesity: a study of results 
obtained at weight reducing courses in Finland, Ann 
Med Intern Fin 52:155, 1963. 

-122- 
10?. Lord WJHs Health education about obesity. The results of a 
two year follow-up. J Coll Gen Prac 11:265, 1966. 
108. Me Cann M. Trulson MF: Long term effects of 'weight reduc¬ 
tion programs. J Am Diet Assoc 31:1103, 1955." 
109. Christakis G, Renzler SH, Archer H, Kraus A: Effect of 
the anticoronary club program on coronary heart dis¬ 
ease risk factor status. JAM 198:597, i960. 
110. Consumers' Association: 10th Anniversary Issue, Oct 5,1967. 
111. Kekwick A,Pawan GLS: Calorie intake in relation to body 
weight changes in the obese. Lancet 2:155, 1956. 
112. Kekwick Af Pawan GLS: Metabolic studies in human obesity 
with isocaloric diets high in fat, protein, or carbo¬ 
hydrates. Metabolism 6:447, 1957. 
113. Kekwick A: Fat mobilizing substance (FMS). Metabolism 
16:787, 1967. 
114. Kekwick A: Effect of FMS in man. Lancet 2:198, 1968. 
115. Kekwick A, Pawan, GLS: The effects of high fat and high 
carbohydrate diets on rates of loss in mice. Metabolism 
13:87, 1964. 
116. Pennington TR: The use of fat in a weight reducing diet, 
Delaware St Mj 23:49, 1951« 
117. Yudkin J, Carey M: The treatment of obesity by the high 
fat diet. Lancet 2:939, i960. 
118. Silverstone JT, Lockheed T: The value of a low carbo¬ 
hydrate diet in obese children. Metabolism 12:710,1963. 
119. Pilington TR, Gainsborough H, Rosenoer 7Y, Carey M: Diet 
and weight reduction in the obese. Lancet 1:856, i960. 
120. Young CM, Scanlan SS, Im HS, Lutwak L: Effect on body 
composition and other parameters in obese young men on 
carbohydrate level of reduction diet. AmJ Clin Nutr 
24:290, 1971. 
121. Wermer SC: Comparison between weight reduction on a high 
calorie fat diet and on an isocaloric regimen high in 
carbohydrate. NEJM 252:66, 1955* 

-123- 
122. Kinsell LW, Gunning B, Michaels GP, Richardson J, Cox SE, 
Lennon C: Calories do count. Metabolism. 13:195, 1964. 
123. Sohar E: Follow-up of obese patients* 14 years after a suc¬ 
cessful reducing diet. Am J Clin Nutr 26:845, 1973* 
124. Bray GA: The myth of dieting in the management of obesity. 
AmJ Clin Nutr 23:1141, 1970 
125. Passmore R, Strong JA, Ritchie FS: The chemical composition 
of the tissue lost by obese patients on a reducing regi¬ 
men. Br J Nutr 12:113, 1968. 
126. Roily F: Dt Med Ws Chr 47:887, 1921. 
127. Bray GA: Effect of caloric restriction on energy expendi¬ 
ture in obese patients. Lancet 2:397, 1969* 
128. Shipman WG: A one page scale of anxiety and depression. 
Psychiat Res Rep 13:289, 1963- 
129* Keys A, Keys M: Eat Well and Stay Well, London, Hobler and 
Stoughton, i960. 
130. Buskirke ER: Physical activity and cardiovascular health. 
Can M Ass J 96:785, 1967. 
131. Bray GA: Pharmacological approach to the treatment of obesity 
in GA Bray and JE Bethune, ads. , Treatment and Management 
of Obesity, New York, Harper and Row, 1974". 
132. Leibowitz SF: Reciprocal hunger-regulating circuits in¬ 
volving alpha ~ and beta-adrenergic receptors located 
respectively, in the ventromedial and lateral hypothalamus 
Proc Nat Acad Sci 67:1063, 1970. 
133. Harris SC, Ivy AC, Searle LM: The mechanism of amphetamine- 
induced loss of weight; a consideration of the theory of 
hunger and appetite. JAMA 134: 1468, 1947. 
134. Pinter EJ, Pattee CJ: Fat-mobilizing action of amphetamine. 
J Clin Invest 47:394, 1968. 
135. Diethylproprion, an appetite supressant. The Medical Letter 
13 (No. 25):101, 1971. 
Gelvin EP, McGavack TH: Dexedrine and weight reduction. NY 
State J Med 49:279, 1949. 
136. 

-124- 
137. LeRiche WH, Csima A: A long-acting appetite suppressant 
drug studied for 24 weeks in both continuous and se¬ 
quential administration. Can Med Assoc J 97:1016,1967. 
138. Patel N, Mock DC, Hagans JA: Comparison of Benzphetamine, 
phenmetrazine, d-amphefamine, and placebo. Clin Parmacl 
Ther 4:330, 1963. 
139* Poindexter A: Appetite suppressant drugs: a controlled clin¬ 
ical comparison of benzphetamine, phenmetraxine, d- 
amphefamine, and placebo. Curr Ther Res 2:354, i960. 
140. Resnick M, Joubert L: A double-blind evaluation of an 
anorexiant, a placebo and diet alone in obese subjects. 
Can Med Assoc J 97:1011, 1967. 
141. Bew K: A study of obesity in general practice. Ulster Med J 
33:43, 1964. 
142. Silverstone JT, Solomon T: The long-term management of 
obesity in general practice. Br J Clin Pract 19:395,1965. 
143. Goodman LS, Gilman A, eds.j The Pharmacological Basis of 
Therapeutics, 4th Ed., McMillan, UY, 1970. 
144. Fenfluramine. The Medical Letter. 15: (8) 33? April 13, 1972. 
145. Nicoloff JT, Drenick EJ: Altered peripheral thyroxine meta¬ 
bolism in severe obesity. Clin Res 14:148, 1966. 
146. Rabinowitz JL, Myers on RM: The effects of triiodothyronine 
on some metabolic parameters of obese individuals. Meta¬ 
bolism 16:68, 1967. 
147. Jelliffe RW, Hill D, Tutter D, et als Death from weight 
control pills. JAMA 208:1843, 1969. 
148. Newburth LH: Obesity. I. Energy metabolism. Physiol Rev 
24:18, 1944. 
149. Johnston LC, Bernstein LM: Body composition and oxygen 
consumption of overweight, normal and underweight women. 
J Lab Clin Med 45: 107, 1955. 
150. Bray GA, Schwartz M, Rozin R, Lister J: Relationships be¬ 
tween oxygen consumption and body consumption of obese 
patients. Metabolism 19:418, 1970. 
151. Bray GA, Melvin KEW, Chopra IF: The effect of triiodo¬ 
thyronine on some metabolic responses of obese patients. 
Am J Clin Nutr 26;715» 1973. 

-125- 
152. Boothby WM, Sandiford I: Summary of the basal metabolism 
data on basal metabolic rate. J Biol Chem 54:783,1922. 
153. Lyon DM, Dunlop DM: The treatment of obesity. A comparison 
of the effects of diet and of thyroid extract. Quart 
J Med 1:331, 1932. 
154. Adlersberg D, Mayer E: Results of prolonged medical treat¬ 
ment of obesity with diet alone, diet and thyroid pre¬ 
paration, and diet and amphetamine. J Clin Endocrinal 
Metab 9s275, 1949. 
155. Asher WL, Dietz RE: Effectiveness of weight reduction in¬ 
volving "diet pills." Curr Ther Res 14:510, 1972. 
156. Bray GA: The effect of diet and triiodothyronine on the 
activity of sn-glycerol-3-phosphate dehydrogenase and 
on the metabolism of glucose and pyuivate by adipose 
tissue of obese patients. J Clin Invest 48:1413,1969. 
157. Deenick DJ, Fisher JLP Prevention of recurrent weight gain 
with large doses of thyroid hormones, Curr Ther Res 
12:570, 1970. 
158. Gwinup G, Poucher R: A controlled study of thyroid analogs 
in the therapy of obesity. Am J Med Sci 254:416, 1967. 
159. Hollingsworth DR, Arnatruda TT, Scheig R: Quantitative and 
qualitative effects of 1-triiodothyronine in massive 
obesity. Metabolism 19:934, 1970. 
160. Rivlin RS: Drug therapy: therapy of obesity with hormones. 
NEJM 292:26, 1975- 
161. Bray GA, Raben MS, Londono J, Gallagher TF: Effects of 
triiodothyronine, growth hormone and anabolic steroids 
on nitrogen excretion and oxygen consumption of obese 
patients. J Clin Endocrinal Metab 33:293, 1971. 
162. Lamki L, Ezrin C, Koven I, Steiner G: L-throxine in the 
treatment of obesity with no increase in loss of lean 
body mass. Metabolism 22: 611, 1973. 
163. Stafforth JS, Morrison NDW: Heart size in thyrotoxicosis. 
Postgrad Med J 44:885, 1968. 
164. Lukensmeyer WW, Hege JN, Theil GB, et al: Calcium and phos¬ 
phorous metabolic studies in triiodothyronine induced 
hypermetabolism. Am J Med Sci 259:282, 1970. 

-126- 
165. Editorial. JAMA 204:328, 1969. 
166. Simeons ATW: The action of chorionic gonadotrophin in the 
obese. Lancet 2:946, 1954. 
167. Came S: The action of chorionic gonadotrophin in the obese. 
Lancet 2:1282, 1961. 
168. Craig LS, Ray RE, Waxier SH, et al: Chorionic gonadotrophin 
in the treatment of obese women. Am J Clin Nutr 12:230, 
1963 
169. Frank BW: The use of chorionic gonadotrophin hormone in the 
treatment of obesity: a double-blind study. Am J Clin 
Nutr 14:133, 1964. 
170. Asher WL, Harper HW: Effect of human chorionic gonadotrophin 
on weight loss, hunger, and feeling of well-being. Am J 
Clin Nutr 26:211, 1973. 
171. Hirsch J, Van Italie TB: The treatment of obesity. Am J Clin 
Nutr 26: 1039» 1073 
172. Simeons, ATW; Chorionic gonadotrophin in the obese. Lancet 
1:47, 1962. 
173. Nisula BC, Morgan FJ, Canfield RE: Evidence that chorionic 
gonadotrophin has intrinsic thyrotropic activity. Biochem 
Biophys Res Commun 58:86, 197^. 
174. Nisula BC, Ketelslegers JM: Thyroid-stimulating activity 
and chorionic gonadotrophin. J Clin Invest 54:494, 197^* 
175* Evans ES, Simpson ME, Evans HM: The role of grov/th hormone 
In calorigenesis and thyroid function. Endocrinology 
63:836, 1958. 
176. Bray GA: Calorigenic effect of human grov/th hormone in obesity. 
J Clin Endocrinal Metab 29;119, 1969* 
177. Lyons HA, Huang CT: Therapeutic use of progesterone in 
alveolar hypoventilation associated with obesity. Am J 
Med 44:881,*1968. 
178. Cullen JM, Bram VC, Reidt WV: The respiratory effects of pro¬ 
gesterone in severe pulmonary emphysema. Am J Med 27:551s 
1959. 
180. Kaplan NM, Jose A: Thyroid as an adjutant to amphetamine 
therapy of obesity. A controlled double-blind study. 
Am J Med Sci 260:105, 1970. 

127- 
181. 
182. 
183. 
184. 
185. 
186. 
187. 
188. 
189. 
190. 
191. 
192. 
193. 
194. 
195. 
196. 
Asher WL, Dietz RE: Effectiveness of weight reduction 
"diet pills." Curr Ther Res 14:510, 1972. 
Glennon JA: Weight reduction - an enigma. Arch Intern ,red 
118:1, 1966. 
Stunkard AJ: New Treatments for obesity: Behavior modifi¬ 
cation, in GA Bray and JE Bethune, eds., Treatment and 
Management of Obesity, New York, Harper and Row, 19"-. 
Wyden P: The Overweight Society, N.Y., William Morrow Inc 
Stunkard A J, Levine H, Fox St The mansvgement of obesity: 
patient self-help and medical treatment. Arch Intern 
Med 125:1067, 1970. 
Wagonsfeld S, Wolowitz HH: Obesity and the self-help group: 
A look at TOPS. Amer J Psychiat 125:249, 1968. 
Bowser LJ, Trulson MF, Bov/ling RD, et al: Methods of reduc¬ 
ing: group therapy vs individual clinic interview. J Amer 
Diet Assoc 29:1193, 1953. 
Sussman MB: Psychosocial correlates for obesity: failure of 
"Calorie collectors." J Amer Diet Assoc 32:423,1956. 
Harvey HI, Simmons WD: Weight reduction: A study of the 
group method: report of progress. Amer J Med Sci 227:521, 
1954. 
Munves ED: Dietetic interviews or group discussion: decision 
in reducing. J Amer Diet Assoc 29:1197, 1953* 
Penick SB, Filion R, Fox S, Stunkard AJ: Behavior modifi¬ 
cation in the treatment of obesity. Psychosom Med 33:49, 
1971. 
Kennedy WA, Foreyt JP: Control of eating behavior in an 
Obese patient by avoidance conditioning. Psychol Rep 22:571, 
1968. 
Harmatz MG, Lupuc P: Behavior modification of overeating 
in a psychiatric population. J Consult Clin Psychol 
32:583, 1968. 
Harris MB: Self-directed program for weight control. J Abnorm 
Psychol 74:263, 1969. 
Stuart RB: Behavioral control of overeating. Behav Res Ther 
5:357, 1967. 
Stuart RB: A three-dimensional program for the treatment of 
obesity. Behav Res Ther 9:177, 1971. 

-128- 
197. Wollersheim JP: Effectiveness of group therapy based upon 
learning principles in the treatment- of overweight 
women. J Abnorm Psychol 76:462, 1970. 
198. Ferster CB, Numberger JI, Lewitt EB: The control of eating. 
J Math 1:87, 1962. 
199. Hagen RL: Group therapy versus bibliotherapy in weight 
reduction. Thesis. Champaign, Univ. Illinois, 1969. 
200. Brightwell DR: Treating obesity with behavior modification. 
Postgrad Med vol 55 no. 4, April 1974. 
201. Buchwald H, Schwartz MZ, Varco RL: Surgical treatment of 
obesity,. Adv Surg 7s235* 1973. 
202. Mason EE: Obesity is a surgical dilemma. Editorial. Surg 
Gynec Obstet 138:425, 1974. 
203. Bloom WL: Fasting as an introduction to the treatment of 
obesity. Metabolism 8:214, 1959. 
204. Keys A, et al.: Human Starvation, Minneapolis, Univ. Minn. 
Press, 1950. 
205. Duncan G. Jensen WK, Fraser RI, Cristofori FC: Correction 
and control of intractable obesity. Practical application 
of intermittent periods of total fasting. JAMA 181:309* 
I960. 
206. Thomson TJ, Runcie J, Miller V: Treatment of obesity by 
total fasting for up to 249 days. Lancet 2:992, 1966. 
207. Drenick EJ, Swensied ME, Bland WH, Tuttle SC: Prolonged 
starvation as treatment of severe obesity. JAMA 187:100, 
1964. 
208. Hunscher MA: A post-hospitalization study of patients 
treated for obesity by fast regimen. Metabolism 
15:383* 1966. 
209. Harrison MT, Marden RW: The long-term value of fasting in 
the treatment of obesity. Lancet 2:1340, 1966. 
210. McCuish AC, Munro JF, Duncan LJP: ^ollrw-up study of 
refractory obesity treated by fasting. Br Med J 1:91, 
1968. 
211. Silverstone JT, Stark JE, Buckle RM: Hunger during total 
starvation. Lancet 1:1343, 1966. 

-129 
212. Cubberley PT, Polster SA, Sohulman CL: Lactic acidosis and 
death after the treatment of obesity by fasting. NEJM 
272:628, 1965. 
213. Ball MF, Canary JJ, Kyle LH: Comparative effects of caloric 
restriction and metabolic acceleration in body composi¬ 
tion in obesity. Ann Int Med 67:60, 1967. 
214. Gilder H, Cornell GN, Thorbyarnarson B: Human energy ex¬ 
penditure in starvation estimated by expired-air analysis. 
J. Appl Physiol 23:297, 1967. 
215. Drenick EJ, Joven CB, Swendseid ME: Occurrence of acute 
Wernicke's encephalopathy during prolonged starvation, 
for the treatment of obesity. NEJM 274:937, i960. 
216. Spencer 10: Death during therapeutic starvation for obesity 
Lancet 1:1288, 1968. 
217. Genuth SM: Effects of oral alanine administration in fasting 
obese subjects. Metabolism 22:927» 1937. 
218. Genuth SM, Castro JH, Vertes V: Weight reduction in obesity 
by put patient semistarvation. JAMA 230:987, 1974. 
219. Blackburn GL, Flatt GP, Clowes GH, et al: Protein-sparing 
therapy during periods of starvation with sepsis or 
trauma. Ann Surg 177:588, 1973. 
220. Apfelbaum M, BoudonP, Lacatis D, et al: Effets metaboliques 
de la diete protidique chez 41 sujets obeses. Presse Med 
78:1917, 1970. 
221. Kremen AJ, et al: An experimental evaluation of the nutritional 
importance of proximal and distal small intestine. Ann 
Surg 140:439, 195^. 
222. Payne JH: Metabolic observations in patients with jejuno- 
colic shunts, Am J Surg 106:273, 1963. 
223. Editorial: Complications of intestinal bypass for obesity, 
JAMA 200:158, 1967. 
224. Sherman CD, Jr, et al: Clinical and metabolic studies 
following bov/el bypassing for obesity, Ann NY Acad Sci 
131:614, 1965. 
225. Payne JH, DeWind LT: Surgical treatment of obesity. Am J 
Surg 118:141, 1969. 
226. Scott HW, Lav/ DH, Sandstead HH, et al: Jejuno-ileal shunt in 
surgical treatment of morbid obesity. Ann Surg 171:770, 1970. 

-130- 
227. Scott HW: Intestinal bypass operations in treatment of 
massive obesity, Hosp Pract 7:104, 1972. 
228. Salmon PA: The results of small intestine bypass operations 
for the treatment of obesity. Surg Gynecol Obstet 
132:965, 1971. 
229. Bleicher J, Cigulsky M, Saporta J: Intestinal bypass oper¬ 
ation for massive obesity. PG Med 55:65, 1974. 
230. Buchwald H: Surgical treatment of obesity. Adv Surg 7:235, 
1973. 
231. Payne JH, DeWind LT, Schwab CE, Kern W: Surgical treatment 
of morbid obesity: sixteen years experience. Arch Surg 
106:432, 1973. 
232. DeWind LT: Jejunoileal bypass surgery for obesity, in GA 
Bray and JE Bethune, eds. Treatment and Management of 
Obesity, New York, Harper and Row, 1974. 
233. Snodgrass PJ: Obesity, Small bowel bypass and liver disease. 
NEJM 282:870, 1970. 
234. Zellman S: The liver in obesity. Arch Int Med 90:141, 1952. 
235. Shibata HR, Mackenzie JR, Huang S: Morphologic changes of 
the liver following small intestinal bypass for obesity. 
Arch Surg 103:229, 1971. 
236. Moxley R: Protein nutrition and liver disease after 
jejunoileal bypass. NEJM April 25, 1974. 
237. Juhl E: ChristoffersonP, Badin H, et al: Hepatic effects 
of obesity treated with jejunoileal anastomosis. NEJM 
285:5^3, 1971. 
238. Solow C, Silberfarb PM, Swift K: Psychosocial effects of 
intestinal bypass surgery for severe obesity. NEJM 
290:300, 1974. 
239. Editorials Shunting operations for morbid obesity: yes or 
no? Med Times 102:l63f 1974. 
240. Printen KNP Mason EE: Gastric surgery for relief of morbid 
obesity. Arch Surg 106:425* 
241. Mason EE, I to C: Gastric bypass in obesity. Surg Clin North 
Am 47:1345, 1967. 
242. Friedman J: Weight problems and the psychological factors. 
J Consult Psychol 23:524, 1959. 







YALE MEDICAL LIBRARY 
Manuscript Theses 
Unpublished theses submitted for the Master’s and Doctor’s degrees and 
deposited in the Yale Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 
i In i%- 
s/2'7 ( 7 7 

